Avirusis a submicroscopicinfectious agentthat replicates only inside the livingcellsof anorganism.[1]Viruses infect alllife forms,from animals and plants tomicroorganisms,includingbacteriaandarchaea.[2][3]Viruses are found in almost everyecosystemon Earth and are the most numerous type of biological entity.[4][5]SinceDmitri Ivanovsky's 1892 article describing a non-bacterialpathogeninfecting tobacco plants and the discovery of thetobacco mosaic virusbyMartinus Beijerinckin 1898,[6]: 4 more than 11,000 of the millions ofvirus specieshave been described in detail.[7][8]The study of viruses is known asvirology,a subspeciality ofmicrobiology.

Virus
"Severe acute respiratory syndrome coronavirus 2"
SARS-CoV-2,a member of the subfamilyCoronavirinae
Virus classificationEdit this classification
(unranked): Virus
Realms

When infected, ahost cellis often forced to rapidly produce thousands of copies of the original virus. When not inside an infected cell or in the process of infecting a cell, viruses exist in the form of independent viral particles, orvirions,consisting of (i)genetic material,i.e., longmoleculesofDNAorRNAthat encode the structure of the proteins by which the virus acts; (ii) aproteincoat, thecapsid,which surrounds and protects the genetic material; and in some cases (iii) an outsideenvelopeoflipids.The shapes of these virus particles range from simplehelicalandicosahedralforms to more complex structures. Most virus species have virions too small to be seen with anoptical microscopeand are one-hundredth the size of most bacteria.

The origins of viruses in theevolutionary history of lifeare still unclear. Some viruses may have evolved fromplasmids,which are pieces of DNA that can move between cells. Other viruses may have evolved from bacteria. In evolution, viruses are an important means ofhorizontal gene transfer,which increasesgenetic diversityin a way analogous tosexual reproduction.[9]Viruses are considered by somebiologiststo be a life form, because they carry genetic material, reproduce, and evolve throughnatural selection,although they lack some key characteristics, such as cell structure, that are generally considered necessary criteria for defining life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life"[10]and asreplicators.[11]

Viruses spreadin many ways. One transmission pathway is through disease-bearing organisms known asvectors:for example, viruses are often transmitted from plant to plant by insects that feed onplant sap,such asaphids;and viruses in animals can be carried byblood-suckinginsects. Many viruses spreadin the airby coughing and sneezing, includinginfluenza viruses,SARS-CoV-2,chickenpox,smallpox,andmeasles.Norovirusandrotavirus,common causes of viralgastroenteritis,are transmitted by thefaecal–oral route,passed by hand-to-mouth contact or in food or water. Theinfectious doseof norovirus required to produce infection in humans is fewer than 100 particles.[12]HIVis one of several virusestransmitted through sexual contactand by exposure to infected blood. The variety of host cells that a virus can infect is called itshost range:this isnarrowfor viruses specialized to infect only a few species, orbroadfor viruses capable of infecting many.[13]: 123–124 

Viral infections in animals provoke animmune responsethat usually eliminates the infecting virus. Immune responses can also be produced byvaccines,which confer anartificially acquired immunityto the specific viral infection. Some viruses, including those that causeHIV/AIDS,HPV infection,andviral hepatitis,evade these immune responses and result inchronicinfections. Several classes ofantiviral drugshave been developed.

Etymology

The English word "virus" comes from theLatinvīrus,which refers topoisonand other noxious liquids.Vīruscomes from the sameIndo-Europeanroot asSanskritviṣa,Avestanvīša,andAncient Greekἰός(iós), which all mean "poison". The first attested use of "virus" in English appeared in 1398 inJohn Trevisa's translation ofBartholomeus Anglicus'sDe Proprietatibus Rerum.[14][15]Virulent,from Latinvirulentus('poisonous'), dates toc. 1400.[16][17]A meaning of 'agent that causes infectious disease' is first recorded in 1728,[15]long before the discovery of viruses byDmitri Ivanovskyin 1892. The Englishpluralisviruses(sometimes alsovira),[18]whereas the Latin word is amass noun,which has noclassicallyattested plural (vīrais used inNeo-Latin[19]). The adjectiveviraldates to 1948.[20]The termvirion(pluralvirions), which dates from 1959,[21]is also used to refer to a single viral particle that is released from the cell and is capable of infecting other cells of the same type.[22]

Origins

Viruses are found wherever there is life and have probably existed since living cellsfirst evolved.[23]The origin of viruses is unclear because they do not form fossils, somolecular techniquesare used to infer how they arose.[24]In addition, viral genetic material occasionally integrates into thegermlineof the host organisms, by which they can be passed onverticallyto the offspring of the host for many generations. This provides an invaluable source of information forpaleovirologiststo trace back ancient viruses that existed as far back as millions of years ago.

There are three main hypotheses that aim to explain the origins of viruses:[25]

Regressive hypothesis
Viruses may have once been small cells thatparasitisedlarger cells. Over time, genes not required by their parasitism were lost. The bacteriarickettsiaandchlamydiaare living cells that, like viruses, can reproduce only inside host cells. They lend support to this hypothesis, as their dependence on parasitism is likely to have caused the loss of genes that enabled them to survive outside a cell. This is also called the "degeneracy hypothesis",[6]: 16 [26]: 11 or "reduction hypothesis".[27]: 24 
Cellular origin hypothesis
Some viruses may have evolved from bits of DNA or RNA that "escaped" from the genes of a larger organism. The escaped DNA could have come fromplasmids(pieces of naked DNA that can move between cells) ortransposons(molecules of DNA that replicate and move around to different positions within the genes of the cell).[13]: 810 Once called "jumping genes", transposons are examples ofmobile genetic elementsand could be the origin of some viruses. They were discovered in maize byBarbara McClintockin 1950.[28]This is sometimes called the "vagrancy hypothesis",[6]: 16 [26]: 11–12 or the "escape hypothesis".[27]: 24 
Co-evolution hypothesis
This is also called the "virus-first hypothesis"[27]: 24 and proposes that viruses may have evolved from complex molecules of protein andnucleic acidat the same time that cells first appeared on Earth and would have been dependent on cellular life for billions of years.Viroidsare molecules of RNA that are not classified as viruses because they lack a protein coat. They have characteristics that are common to several viruses and are often calledsubviral agents.[6]: 55 Viroids are important pathogens of plants.[13]: 791 They do not code for proteins but interact with the host cell and use the host machinery for their replication.[29]Thehepatitis delta virusof humans has an RNAgenomesimilar to viroids but has a protein coat derived from hepatitis B virus and cannot produce one of its own. It is, therefore, a defective virus. Although hepatitis delta virus genome may replicate independently once inside a host cell, it requires the help of hepatitis B virus to provide a protein coat so that it can be transmitted to new cells.[13]: 460 In similar manner, thesputnik virophageis dependent onmimivirus,which infects the protozoanAcanthamoebacastellanii.[30]These viruses, which are dependent on the presence of other virus species in the host cell, are called "satellites"and may represent evolutionary intermediates of viroids and viruses.[26]: 777 [6]: 55–57 

In the past, there were problems with all of these hypotheses: the regressive hypothesis did not explain why even the smallest of cellular parasites do not resemble viruses in any way. The escape hypothesis did not explain the complex capsids and other structures on virus particles. The virus-first hypothesis contravened the definition of viruses in that they require host cells.[27]: 24 Viruses are now recognised as ancient and as having origins that pre-date the divergence of life into thethree domains.[27]: 28 This discovery has led modern virologists to reconsider and re-evaluate these three classical hypotheses.[27]: 28 

The evidence for anancestral world of RNAcells[27]: 26 and computer analysis of viral and host DNA sequences give a better understanding of the evolutionary relationships between different viruses and may help identify the ancestors of modern viruses. To date, such analyses have not proved which of these hypotheses is correct.[27]: 26 It seems unlikely that all currently known viruses have a common ancestor, and viruses have probably arisen numerous times in the past by one or more mechanisms.[31]

Microbiology

Discovery

The first evidence of the existence of viruses came from experiments with filters that had pores small enough to retain bacteria. In 1892,Dmitri Ivanovskyused one of these filters to show that sap from a diseased tobacco plant remained infectious to healthy tobacco plants despite having been filtered. Martinus Beijerinck called the filtered, infectious substance a "virus" and this discovery is considered to be the beginning of virology. The subsequent discovery and partial characterization ofbacteriophagesbyFrederick TwortandFélix d'Herellefurther catalyzed the field, and by the early 20th century many viruses had been discovered. In 1926,Thomas Milton Riversdefined viruses as obligate parasites. Viruses were demonstrated to be particles, rather than a fluid, byWendell Meredith Stanley,and the invention of theelectron microscopein 1931 allowed their complex structures to be visualised.[32]

Life properties

Scientific opinions differ on whether viruses are a form of life or organic structures that interact with living organisms.[11]They have been described as "organisms at the edge of life",[10]since they resemble organisms in that they possessgenes,evolve bynatural selection,[33]and reproduce by creating multiple copies of themselves through self-assembly. Although they have genes, they do not have a cellular structure, which is often seen as the basic unit of life. Viruses do not have their ownmetabolismand require a host cell to make new products. They therefore cannot naturally reproduce outside a host cell[34]—although some bacteria such asrickettsiaandchlamydiaare considered living organisms despite the same limitation.[35][36]Accepted forms of life usecell divisionto reproduce, whereas viruses spontaneously assemble within cells. They differ fromautonomous growthofcrystalsas they inherit genetic mutations while being subject to natural selection. Virus self-assembly within host cells has implications for the study of theorigin of life,as it lends further credence to the hypothesis that life could have started asself-assembling organic molecules.[2]Thevirocellmodel first proposed byPatrick Forterreconsiders the infected cell to be the "living form" of viruses and that virus particles (virions) are analogous tospores.[37]Although the living versus non-living debate continues, the virocell model has gained some acceptance.[38]

Structure

Virions of some of the most common human viruses with their relative size. The nucleic acids are not to scale.
Diagram of how a viruscapsidcan be constructed using multiple copies of just two protein molecules
Structure oftobacco mosaic virus:RNAcoiled in a helix of repeating protein sub-units
Structure of icosahedraladenovirus.Electron micrograph with an illustration to show shape
Structure ofchickenpoxvirus. They have a lipid envelope.
Structure of an icosahedralcowpea mosaic virus
BacteriophageEscherichia virus MS2capsid. This spherical virus also has icosahedral symmetry.

Viruses display a wide diversity of sizes and shapes, called 'morphologies'. In general, viruses are much smaller than bacteria and more than a thousand bacteriophage viruses would fit inside anEscherichia colibacterium's cell.[39]: 98 Many viruses that have been studied are spherical and have a diameter between 20 and 300nanometres.Somefiloviruses,which are filaments, have a total length of up to 1400 nm; their diameters are only about 80 nm.[26]: 33–55 Most viruses cannot be seen with anoptical microscope,so scanning and transmissionelectron microscopesare used to visualise them.[26]: 33–37 To increase the contrast between viruses and the background, electron-dense "stains" are used. These are solutions ofsaltsof heavy metals, such astungsten,that scatter the electrons from regions covered with the stain. When virions are coated with stain (positive staining), fine detail is obscured.Negative stainingovercomes this problem by staining the background only.[40]

A complete virus particle, known as avirion,consists of nucleic acid surrounded by a protective coat of protein called acapsid.These are formed from protein subunits calledcapsomeres.[26]: 40 Viruses can have alipid"envelope" derived from the hostcell membrane.The capsid is made from proteins encoded by the viralgenomeand its shape serves as the basis for morphological distinction.[41][42]Virally-coded protein subunits will self-assemble to form a capsid, in general requiring the presence of the virus genome. Complex viruses code for proteins that assist in the construction of their capsid. Proteins associated with nucleic acid are known asnucleoproteins,and the association of viral capsid proteins with viral nucleic acid is called a nucleocapsid. The capsid and entire virus structure can be mechanically (physically) probed throughatomic force microscopy.[43][44]In general, there are five main morphological virus types:

Helical
These viruses are composed of a single type of capsomere stacked around a central axis to form ahelicalstructure, which may have a central cavity, or tube. This arrangement results in virions which can be short and highly rigid rods, or long and very flexible filaments. The genetic material (typically single-stranded RNA, but single-stranded DNA in some cases) is bound into the protein helix by interactions between the negatively charged nucleic acid and positive charges on the protein. Overall, the length of a helical capsid is related to the length of the nucleic acid contained within it, and the diameter is dependent on the size and arrangement of capsomeres. The well-studied tobacco mosaic virus[26]: 37 and inovirus[45]are examples of helical viruses.
Icosahedral
Most animal viruses are icosahedral or near-spherical with chiralicosahedral symmetry.Aregular icosahedronis the optimum way of forming a closed shell from identical subunits. The minimum number of capsomeres required for each triangular face is 3, which gives 60 for the icosahedron. Many viruses, such as rotavirus, have more than 60 capsomers and appear spherical but they retain this symmetry. To achieve this, the capsomeres at the apices are surrounded by five other capsomeres and are called pentons. Capsomeres on the triangular faces are surrounded by six others and are calledhexons.[26]: 40, 42 Hexons are in essence flat and pentons, which form the 12 vertices, are curved. The same protein may act as the subunit of both the pentamers and hexamers or they may be composed of different proteins.[46]
Prolate
This is an icosahedron elongated along the fivefold axis and is a common arrangement of the heads of bacteriophages. This structure is composed of a cylinder with a cap at either end.[47]
Enveloped
Some species of virusenvelopthemselves in a modified form of one of thecell membranes,either the outer membrane surrounding an infected host cell or internal membranes such as a nuclear membrane orendoplasmic reticulum,thus gaining an outer lipid bilayer known as aviral envelope.This membrane is studded with proteins coded for by the viral genome and host genome; the lipid membrane itself and any carbohydrates present originate entirely from the host.Influenza virus,HIV(which causesAIDS), andsevere acute respiratory syndrome coronavirus 2(which causesCOVID-19)[48]use this strategy. Most enveloped viruses are dependent on the envelope for their infectivity.[26]: 42–43 
Complex
These viruses possess a capsid that is neither purely helical nor purely icosahedral, and that may possess extra structures such as protein tails or a complex outer wall. Some bacteriophages, such asEnterobacteria phage T4,have a complex structure consisting of an icosahedral head bound to a helical tail, which may have ahexagonalbase plate with protruding protein tail fibres. This tail structure acts like a molecular syringe, attaching to the bacterial host and then injecting the viral genome into the cell.[49]

Thepoxvirusesare large, complex viruses that have an unusual morphology. The viral genome is associated with proteins within a central disc structure known as anucleoid.The nucleoid is surrounded by a membrane and two lateral bodies of unknown function. The virus has an outer envelope with a thick layer of protein studded over its surface. The whole virion is slightlypleomorphic,ranging from ovoid to brick-shaped.[50]

Giant viruses

Mimivirusis one of the largest characterised viruses, with a capsid diameter of 400 nm. Protein filaments measuring 100 nm project from the surface. The capsid appears hexagonal under an electron microscope, therefore the capsid is probably icosahedral.[51]In 2011, researchers discovered the largest then known virus in samples of water collected from the ocean floor off the coast of Las Cruces, Chile. Provisionally namedMegaviruschilensis,it can be seen with a basic optical microscope.[52]In 2013, thePandoravirusgenus was discovered in Chile and Australia, and has genomes about twice as large as Megavirus and Mimivirus.[53]All giant viruses have dsDNA genomes and they are classified into several families:Mimiviridae,Pithoviridae,Pandoraviridae,Phycodnaviridae,and theMollivirusgenus.[54]

Some viruses that infectArchaeahave complex structures unrelated to any other form of virus, with a wide variety of unusual shapes, ranging from spindle-shaped structures to viruses that resemble hooked rods, teardrops or even bottles. Other archaeal viruses resemble the tailed bacteriophages, and can have multiple tail structures.[55]

Genome

Genomic diversity among viruses
Property Parameters
Nucleic acid
  • DNA
  • RNA
  • Both DNA and RNA (at different stages in the life cycle)
Shape
  • Linear
  • Circular
  • Segmented
Strandedness
  • Single-stranded (ss)
  • Double-stranded (ds)
  • Double-stranded with regions of single-strandedness
Sense
  • Positive sense (+)
  • Negative sense (−)
  • Ambisense (+/−)

An enormous variety of genomic structures can be seen amongviral species;as a group, they contain more structural genomic diversity than plants, animals, archaea, or bacteria. There are millions of different types of viruses,[8]although fewer than 7,000 types have been described in detail.[6]: 49 As of January 2021, theNCBIVirus genome database has more than 193,000 complete genome sequences,[56]but there are doubtlessly many more to be discovered.[57][58]

A virus has either aDNAor anRNAgenome and is called aDNA virusor anRNA virus,respectively. Most viruses have RNA genomes. Plant viruses tend to have single-stranded RNA genomes and bacteriophages tend to have double-stranded DNA genomes.[26]: 96–99 

Viral genomes are circular, as in thepolyomaviruses,or linear, as in theadenoviruses.The type of nucleic acid is irrelevant to the shape of the genome. Among RNA viruses and certain DNA viruses, the genome is often divided into separate parts, in which case it is called segmented. For RNA viruses, each segment often codes for only one protein and they are usually found together in one capsid. All segments are not required to be in the same virion for the virus to be infectious, as demonstrated bybrome mosaic virusand several other plant viruses.[26]: 33–35 

A viral genome, irrespective of nucleic acid type, is almost always either single-stranded (ss) or double-stranded (ds). Single-stranded genomes consist of an unpaired nucleic acid, analogous to one-half of a ladder split down the middle. Double-stranded genomes consist of two complementary paired nucleic acids, analogous to a ladder. The virus particles of some virus families, such as those belonging to theHepadnaviridae,contain a genome that is partially double-stranded and partially single-stranded.[26]: 96–99 

For most viruses with RNA genomes and some with single-stranded DNA (ssDNA) genomes, the single strands are said to be eitherpositive-sense(called the 'plus-strand') ornegative-sense(called the 'minus-strand'), depending on if they are complementary to the viralmessenger RNA(mRNA). Positive-sense viral RNA is in the same sense as viral mRNA and thus at least a part of it can be immediatelytranslatedby the host cell. Negative-sense viral RNA is complementary to mRNA and thus must be converted to positive-sense RNA by anRNA-dependent RNA polymerasebefore translation. DNA nomenclature for viruses with genomic ssDNA is similar to RNA nomenclature, in that positive-strand viral ssDNA is identical in sequence to the viral mRNA and is thus a coding strand, while negative-sense viral ssDNA is complementary to the viral mRNA and is thus a template strand.[26]: 96–99 Several types of ssDNA and ssRNA viruses have genomes that areambisensein that transcription can occur off both strands in a double-stranded replicative intermediate. Examples includegeminiviruses,which are ssDNA plant viruses andarenaviruses,which are ssRNA viruses of animals.[59]

Genome size

Genome size varies greatly between species. The smallest—the ssDNA circoviruses, familyCircoviridae—code for only two proteins and have a genome size of only two kilobases;[60]the largest—thepandoraviruses—have genome sizes of around two megabases which code for about 2500 proteins.[53]Virus genes rarely haveintronsand often are arranged in the genome so that theyoverlap.[61]

In general, RNA viruses have smaller genome sizes than DNA viruses because of a higher error-rate when replicating, and have a maximum upper size limit.[24]Beyond this, errors when replicating render the virus useless or uncompetitive. To compensate, RNA viruses often have segmented genomes—the genome is split into smaller molecules—thus reducing the chance that an error in a single-component genome will incapacitate the entire genome. In contrast, DNA viruses generally have larger genomes because of the high fidelity of their replication enzymes.[62]Single-strand DNA viruses are an exception to this rule, as mutation rates for these genomes can approach the extreme of the ssRNA virus case.[63]

Genetic mutation and recombination

Evolution mechanisms of Influenza A virus. (A)Antigenic Drift:Gradual accumulation of mutations in the genome of IAVs leads to emergence of new virus variants. (B)Antigenic Shift:The reassortment of genetic segments between two or more invading IAVs in a host cell can lead to emergence of an antigenically novel subtype.

Viruses undergo genetic change by several mechanisms. These include a process calledantigenic driftwhere individual bases in the DNA or RNAmutateto other bases. Most of thesepoint mutationsare "silent" —they do not change the protein that the gene encodes—but others can confer evolutionary advantages such as resistance toantiviral drugs.[64][65]Antigenic shiftoccurs when there is a major change in the genome of the virus. This can be a result ofrecombinationorreassortment.TheInfluenza A virusis highly prone to reassortment; occasionally this has resulted in novelstrainswhich have causedpandemics.[66]RNA viruses often exist asquasispeciesor swarms of viruses of the same species but with slightly different genome nucleoside sequences. Such quasispecies are a prime target for natural selection.[67]

Segmented genomes confer evolutionary advantages; different strains of a virus with a segmented genome can shuffle and combine genes and produce progeny viruses (or offspring) that have unique characteristics. This is called reassortment or 'viral sex'.[68]

Genetic recombinationis a process by which a strand of DNA (or RNA) is broken and then joined to the end of a different DNA (or RNA) molecule. This can occur when viruses infect cells simultaneously and studies ofviral evolutionhave shown that recombination has been rampant in the species studied.[69]Recombination is common to both RNA and DNA viruses.[70][71]

Coronaviruseshave a single-strand positive-senseRNAgenome. Replication of thegenomeis catalyzed by anRNA-dependent RNA polymerase.The mechanism ofrecombinationused by coronaviruses likely involves template switching by the polymerase during genome replication.[72]This process appears to be an adaptation for coping with genome damage.[73]

Replication cycle

A typical virus replication cycle
Some bacteriophages inject theirgenomesinto bacterial cells (not to scale)

Viral populations do not grow through cell division, because they are acellular. Instead, they use the machinery and metabolism of a host cell to produce multiple copies of themselves, and they assemble in the cell.[74]When infected, the host cell is forced to rapidly produce thousands of copies of the original virus.[75]

Their life cycle differs greatly between species, but there are six basic stages in their life cycle:[26]: 75–91 

Attachmentis a specific binding between viral capsid proteins and specific receptors on the host cellular surface. This specificity determines the host range and type of host cell of a virus. For example, HIV infects a limited range of humanleucocytes.This is because its surface protein,gp120,specifically interacts with theCD4molecule—achemokine receptor—which is most commonly found on the surface ofCD4+T-Cells.This mechanism has evolved to favour those viruses that infect only cells in which they are capable of replication. Attachment to the receptor can induce the viral envelope protein to undergo changes that result in thefusionof viral and cellular membranes, or changes of non-enveloped virus surface proteins that allow the virus to enter.[76]

Penetrationorviral entryfollows attachment: Virions enter the host cell through receptor-mediatedendocytosisormembrane fusion.The infection of plant and fungal cells is different from that of animal cells. Plants have a rigid cell wall made ofcellulose,and fungi one of chitin, so most viruses can get inside these cells only after trauma to the cell wall.[6]: 70 Nearly all plant viruses (such as tobacco mosaic virus) can also move directly from cell to cell, in the form of single-stranded nucleoprotein complexes, through pores calledplasmodesmata.[77]Bacteria, like plants, have strong cell walls that a virus must breach to infect the cell. Given that bacterial cell walls are much thinner than plant cell walls due to their much smaller size, some viruses have evolved mechanisms that inject their genome into the bacterial cell across the cell wall, while the viral capsid remains outside.[6]: 71 

Uncoatingis a process in which the viral capsid is removed: This may be by degradation by viral enzymes or host enzymes or by simple dissociation; the end-result is the releasing of the viral genomic nucleic acid.[78]

Replicationof viruses involves primarily multiplication of the genome. Replication involves the synthesis of viral messenger RNA (mRNA) from "early" genes (with exceptions for positive-sense RNA viruses), viralprotein synthesis,possible assembly of viral proteins, then viral genome replication mediated by early or regulatory protein expression. This may be followed, for complex viruses with larger genomes, by one or more further rounds of mRNA synthesis: "late" gene expression is, in general, of structural or virion proteins.[79]

Assembly– Following the structure-mediated self-assembly of the virus particles, some modification of the proteins often occurs. In viruses such as HIV, this modification (sometimes called maturation) occurs after the virus has been released from the host cell.[80]

Release– Viruses can bereleasedfrom the host cell bylysis,a process that kills the cell by bursting its membrane and cell wall if present: this is a feature of many bacterial and some animal viruses. Some viruses undergo alysogenic cyclewhere the viral genome is incorporated bygenetic recombinationinto a specific place in the host's chromosome. The viral genome is then known as a "provirus"or, in the case of bacteriophages a"prophage".[13]: 836 Whenever the host divides, the viral genome is also replicated. The viral genome is mostly silent within the host. At some point, the provirus or prophage may give rise to the active virus, which may lyse the host cells.[6]: 243–259 Enveloped viruses (e.g., HIV) typically are released from the host cell bybudding.During this process, the virus acquires its envelope, which is a modified piece of the host's plasma or other, internal membrane.[6]: 185–187 

Genome replication

The genetic material within virus particles, and the method by which the material is replicated, varies considerably between different types of viruses.

DNA viruses
The genome replication of mostDNA virusestakes place in the cell'snucleus.If the cell has the appropriate receptor on its surface, these viruses enter the cell either by direct fusion with the cell membrane (e.g., herpesviruses) or—more usually—by receptor-mediated endocytosis. Most DNA viruses are entirely dependent on the host cell's DNA and RNA synthesising machinery and RNA processing machinery. Viruses with larger genomes may encode much of this machinery themselves. In eukaryotes, the viral genome must cross the cell's nuclear membrane to access this machinery, while in bacteria it need only enter the cell.[13]: 118 [26]: 78 
RNA viruses
Replication ofRNA virusesusually takes place in thecytoplasm.RNA viruses can be placed into four different groups depending on their modes of replication. Thepolarity(whether or not it can be used directly by ribosomes to make proteins) of single-stranded RNA viruses largely determines the replicative mechanism; the other major criterion is whether the genetic material is single-stranded or double-stranded. All RNA viruses use their ownRNA replicaseenzymes to create copies of their genomes.[26]: 79 
Reverse transcribing viruses
Reverse transcribing viruseshave ssRNA (Retroviridae,Metaviridae,Pseudoviridae) or dsDNA (Caulimoviridae,andHepadnaviridae) in their particles. Reverse transcribing viruses with RNA genomes (retroviruses) use a DNA intermediate to replicate, whereas those with DNA genomes (pararetroviruses) use an RNA intermediate during genome replication. Both types use areverse transcriptase,or RNA-dependent DNA polymerase enzyme, to carry out the nucleic acid conversion. Retroviruses integrate the DNA produced byreverse transcriptioninto the host genome as a provirus as a part of the replication process; pararetroviruses do not, although integrated genome copies of especially plant pararetroviruses can give rise to infectious virus.[81]They are susceptible toantiviral drugsthat inhibit the reverse transcriptase enzyme, e.g.zidovudineandlamivudine.An example of the first type is HIV, which is a retrovirus. Examples of the second type are theHepadnaviridae,which includes Hepatitis B virus.[26]: 88–89 

Cytopathic effects on the host cell

The range of structural and biochemical effects that viruses have on the host cell is extensive.[26]: 115–146 These are called 'cytopathic effects'.[26]: 115 Most virus infections eventually result in the death of the host cell. The causes of death include cell lysis, alterations to the cell's surface membrane andapoptosis.[82]Often cell death is caused by cessation of its normal activities because of suppression by virus-specific proteins, not all of which are components of the virus particle.[83]The distinction between cytopathic and harmless is gradual. Some viruses, such asEpstein–Barr virus,can cause cells to proliferate without causing malignancy,[84]while others, such aspapillomaviruses,are established causes of cancer.[85]

Dormant and latent infections

Some viruses cause no apparent changes to the infected cell. Cells in which the virus islatentand inactive show few signs of infection and often function normally.[86]This causes persistent infections and the virus is often dormant for many months or years. This is often the case withherpes viruses.[87][88]

Host range

Viruses are by far the most abundant biological entities on Earth and they outnumber all the others put together.[89]They infect all types of cellular life including animals, plants,bacteriaandfungi.[6]: 49 Different types of viruses can infect only a limited range of hosts and many are species-specific. Some, such assmallpox virusfor example, can infect only one species—in this case humans,[13]: 643 and are said to have a narrowhost range.Other viruses, such as rabies virus, can infect different species of mammals and are said to have a broad range.[13]: 631 The viruses that infect plants are harmless to animals, and most viruses that infect other animals are harmless to humans.[6]: 272 The host range of some bacteriophages is limited to a singlestrainof bacteria and they can be used to trace the source of outbreaks of infections by a method calledphage typing.[90]The complete set of viruses in an organism or habitat is called thevirome;for example, all human viruses constitute thehuman virome.[91]

Novel viruses

Anovel virusis one that has not previously been recorded. It can be a virus that is isolated from itsnatural reservoiror isolated as the result ofspread to an animal or human hostwhere the virus had not been identified before. It can be anemergent virus,one that represents a new virus, but it can also be an extant virus that has not beenpreviously identified.[92]TheSARS-CoV-2coronavirus that caused the COVID-19 pandemic is an example of a novel virus.[93]

Classification

Classification seeks to describe the diversity of viruses by naming and grouping them on the basis of similarities. In 1962,André Lwoff,Robert Horne,and Paul Tournier were the first to develop a means of virus classification, based on theLinnaeanhierarchical system.[94]This system based classification onphylum,class,order,family,genus,andspecies.Viruses were grouped according to their shared properties (not those of their hosts) and the type of nucleic acid forming their genomes.[95]In 1966, theInternational Committee on Taxonomy of Viruses(ICTV) was formed. The system proposed by Lwoff, Horne and Tournier was initially not accepted by the ICTV because the small genome size of viruses and their high rate of mutation made it difficult to determine their ancestry beyond order. As such, theBaltimore classificationsystem has come to be used to supplement the more traditional hierarchy.[96]Starting in 2018, the ICTV began to acknowledge deeper evolutionary relationships between viruses that have been discovered over time and adopted a 15-rank classification system ranging from realm to species.[97]Additionally, some species within the same genus are grouped into agenogroup.[98][99]

ICTV classification

The ICTV developed the current classification system and wrote guidelines that put a greater weight on certain virus properties to maintain family uniformity. A unified taxonomy (a universal system for classifying viruses) has been established.[100]Only a small part of the total diversity of viruses has been studied.[101]As of 2022, 6 realms, 10 kingdoms, 17 phyla, 2 subphyla, 40 classes, 72 orders, 8 suborders,264 families, 182 subfamilies,2,818 genera, 84 subgenera,and11,273 speciesof viruses have been defined by the ICTV.[7]

The general taxonomic structure of taxon ranges and the suffixes used in taxonomic names are shown hereafter. As of 2022, the ranks of subrealm, subkingdom, and subclass are unused, whereas all other ranks are in use.[7]

Realm(-viria)
Subrealm (-vira)
Kingdom(-virae)
Subkingdom (-virites)
Phylum(-viricota)
Subphylum (-viricotina)
Class(-viricetes)
Subclass (-viricetidae)
Order(-virales)
Suborder (-virineae)
Family(-viridae)
Subfamily (-virinae)
Genus(-virus)
Subgenus (-virus)
Species

Baltimore classification

The Baltimore Classification of viruses is based on the method of viralmRNAsynthesis

The Nobel Prize-winning biologistDavid Baltimoredevised theBaltimore classificationsystem.[102][103]The ICTV classification system is used in conjunction with the Baltimore classification system in modern virus classification.[104][105][106]

The Baltimore classification of viruses is based on the mechanism ofmRNAproduction. Viruses must generate mRNAs from their genomes to produce proteins and replicate themselves, but different mechanisms are used to achieve this in each virus family. Viral genomes may be single-stranded (ss) or double-stranded (ds), RNA or DNA, and may or may not usereverse transcriptase(RT). In addition, ssRNA viruses may be eithersense(+) or antisense (−). This classification places viruses into seven groups:


Role in human disease

Overview of the main types of viral infection and the most notable species involved[107]

Examples of common human diseases caused by viruses include thecommon cold,influenza,chickenpox,andcold sores.Many serious diseases such asrabies,Ebola virus disease,AIDS (HIV),avian influenza,andSARSare caused by viruses. The relative ability of viruses to cause disease is described in terms ofvirulence.Other diseases are under investigation to discover if they have a virus as the causative agent, such as the possible connection betweenhuman herpesvirus 6(HHV6) and neurological diseases such asmultiple sclerosisandchronic fatigue syndrome.[108]There is controversy over whether thebornavirus,previously thought to causeneurologicaldiseases in horses, could be responsible forpsychiatricillnesses in humans.[109]

Viruses have different mechanisms by which they produce disease in an organism, which depends largely on the viral species. Mechanisms at the cellular level primarily include cell lysis, the breaking open and subsequent death of the cell. Inmulticellular organisms,if enough cells die, the whole organism will start to suffer the effects. Although viruses cause disruption of healthyhomeostasis,resulting in disease, they may exist relatively harmlessly within an organism. An example would include the ability of theherpes simplex virus,which causes cold sores, to remain in a dormant state within the human body. This is called latency[110]and is a characteristic of the herpes viruses, including Epstein–Barr virus, which causes glandular fever, andvaricella zoster virus,which causes chickenpox andshingles.Most people have been infected with at least one of these types of herpes virus.[111]These latent viruses might sometimes be beneficial, as the presence of the virus can increase immunity against bacterial pathogens, such asYersinia pestis.[112]

Some viruses can cause lifelong orchronicinfections, where the viruses continue to replicate in the body despite the host's defence mechanisms.[113]This is common in hepatitis B virus and hepatitis C virus infections. People chronically infected are known as carriers, as they serve as reservoirs of infectious virus.[114]In populations with a high proportion of carriers, the disease is said to beendemic.[115]

Epidemiology

Viralepidemiologyis the branch of medical science that deals with the transmission and control of virus infections in humans. Transmission of viruses can be vertical, which means from mother to child, or horizontal, which means from person to person. Examples ofvertical transmissioninclude hepatitis B virus and HIV, where the baby is born already infected with the virus.[116]Another, more rare, example is thevaricella zoster virus,which, although causing relatively mild infections in children and adults, can be fatal to the foetus and newborn baby.[117]

Horizontal transmissionis the most common mechanism of spread of viruses in populations.[118]Horizontal transmission can occur when body fluids are exchanged during sexual activity, by exchange of saliva or when contaminated food or water is ingested. It can also occur whenaerosolscontaining viruses are inhaled or by insectvectorssuch as when infected mosquitoes penetrate the skin of a host.[118]Most types of viruses are restricted to just one or two of these mechanisms and they are referred to as "respiratory viruses" or "enteric viruses" and so forth. The rate or speed of transmission of viral infections depends on factors that include population density, the number of susceptible individuals, (i.e., those not immune),[119]the quality of healthcare and the weather.[120]

Epidemiology is used to break the chain of infection in populations during outbreaks ofviral diseases.[13]: 264 Control measures are used that are based on knowledge of how the virus is transmitted. It is important to find the source, or sources, of the outbreak and to identify the virus. Once the virus has been identified, the chain of transmission can sometimes be broken by vaccines. When vaccines are not available, sanitation and disinfection can be effective. Often, infected people are isolated from the rest of the community, and those that have been exposed to the virus are placed inquarantine.[13]: 894 To control theoutbreakoffoot-and-mouth diseasein cattle in Britain in 2001, thousands of cattle were slaughtered.[121]Most viral infections of humans and other animals haveincubation periodsduring which the infection causes no signs or symptoms.[13]: 170 Incubation periods for viral diseases range from a few days to weeks, but are known for most infections.[13]: 170–172 Somewhat overlapping, but mainly following the incubation period, there is a period of communicability—a time when an infected individual or animal is contagious and can infect another person or animal.[13]: 170–172 This, too, is known for many viral infections, and knowledge of the length of both periods is important in the control of outbreaks.[13]: 272 When outbreaks cause an unusually high proportion of cases in a population, community, or region, they are called epidemics. If outbreaks spread worldwide, they are calledpandemics.[13]: 891 

Epidemics and pandemics

Transmission electron microscopeimage of a recreated 1918 influenza virus

Apandemicis a worldwideepidemic.The1918 flu pandemic,which lasted until 1919, was acategory 5influenza pandemic caused by an unusually severe and deadly influenza A virus. The victims were often healthy young adults, in contrast to most influenza outbreaks, which predominantly affect juvenile, elderly, or otherwise-weakened patients.[26]: 409–415 Older estimates say it killed 40–50 million people,[122]while more recent research suggests that it may have killed as many as 100 million people, or 5% of the world's population in 1918.[123]

Although viral pandemics are rare events, HIV—which evolved from viruses found in monkeys and chimpanzees—has been pandemic since at least the 1980s.[124]During the 20th century there were four pandemics caused by influenza virus and those that occurred in 1918, 1957 and 1968 were severe.[125]Most researchers believe that HIV originated insub-Saharan Africaduring the 20th century;[126]it is now a pandemic, with an estimated 37.9 million people now living with the disease worldwide.[127]There were about 770,000 deaths from AIDS in 2018.[128]TheJoint United Nations Programme on HIV/AIDS(UNAIDS) and theWorld Health Organization(WHO) estimate that AIDS has killed more than 25 million people since it was first recognised on 5 June 1981, making it one of the most destructive epidemics in recorded history.[129]In 2007 there were 2.7 million new HIV infections and 2 million HIV-related deaths.[130]

Ebola (top) and Marburg viruses (bottom)

Several highly lethal viral pathogens are members of theFiloviridae.Filoviruses are filament-like viruses that causeviral hemorrhagic fever,and includeebolavirusesandmarburgviruses.Marburg virus,first discovered in 1967, attracted widespread press attention in April 2005 for an outbreak inAngola.[131]Ebola virus diseasehas also causedintermittent outbreakswith high mortality rates since 1976 when it was first identified. The worst and most recent one is the 2013–2016West Africa epidemic.[132]

Except for smallpox, most pandemics are caused by newly evolved viruses. These"emergent"viruses are usually mutants of less harmful viruses that have circulated previously either in humans or other animals.[133]

Severe acute respiratory syndrome (SARS) andMiddle East respiratory syndrome(MERS) are caused by new types ofcoronaviruses.Other coronaviruses are known to cause mild infections in humans,[134]so the virulence and rapid spread of SARS infections—that by July 2003 had caused around 8,000 cases and 800 deaths—was unexpected and most countries were not prepared.[135]

A related coronavirus,severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2),thought to have originated in bats, emerged inWuhan,China in November 2019 and spread rapidly around the world. Infections with the virus caused theCOVID-19 pandemicthat started in 2020.[93][136][137]Unprecedented restrictions in peacetime were placed on international travel,[138]andcurfewswere imposed in several major cities worldwide in response to the pandemic.[139]

Cancer

Viruses are an established cause of cancer in humans and other species. Viral cancers occur only in a minority of infected persons (or animals). Cancer viruses come from a range of virus families, including both RNA and DNA viruses, and so there is no single type of "oncovirus"(an obsolete term originally used for acutely transforming retroviruses). The development of cancer is determined by a variety of factors such as host immunity[140]and mutations in the host.[141]Viruses accepted to cause human cancers include some genotypes ofhuman papillomavirus,hepatitis B virus,hepatitis C virus,Epstein–Barr virus,Kaposi's sarcoma-associated herpesvirusandhuman T-lymphotropic virus.The most recently discovered human cancer virus is a polyomavirus (Merkel cell polyomavirus) that causes most cases of a rare form of skin cancer calledMerkel cell carcinoma.[142] Hepatitis viruses can develop into a chronic viral infection that leads toliver cancer.[143][144]Infection by human T-lymphotropic virus can lead totropical spastic paraparesisandadult T-cell leukaemia.[145]Human papillomaviruses are an established cause of cancers ofcervix,skin,anus,andpenis.[146]Within theHerpesviridae,Kaposi's sarcoma-associated herpesviruscausesKaposi's sarcomaandbody-cavity lymphoma,and Epstein–Barr virus causesBurkitt's lymphoma,Hodgkin's lymphoma,Blymphoproliferative disorder,andnasopharyngeal carcinoma.[147]Merkel cell polyomavirus closely related toSV40and mouse polyomaviruses that have been used as animal models for cancer viruses for over 50 years.[148]

Host defence mechanisms

The body's first line of defence against viruses is theinnate immune system.This comprises cells and other mechanisms that defend the host from infection in a non-specific manner. This means that the cells of the innate system recognise, and respond to, pathogens in a generic way, but, unlike theadaptive immune system,it does not confer long-lasting or protective immunity to the host.[149]

RNA interferenceis an important innate defence against viruses.[150]Many viruses have a replication strategy that involves double-stranded RNA (dsRNA). When such a virus infects a cell, it releases its RNA molecule or molecules, which immediately bind to a protein complex called adicerthat cuts the RNA into smaller pieces. A biochemical pathway—theRISC complex—is activated, which ensures cell survival by degrading the viral mRNA. Rotaviruses have evolved to avoid this defence mechanism by not uncoating fully inside the cell, and releasing newly produced mRNA through pores in the particle's inner capsid. Their genomic dsRNA remains protected inside the core of the virion.[151][152]

When theadaptive immune systemof avertebrateencounters a virus, it produces specificantibodiesthat bind to the virus and often render it non-infectious. This is calledhumoral immunity.Two types of antibodies are important. The first, calledIgM,is highly effective at neutralising viruses but is produced by the cells of the immune system only for a few weeks. The second, calledIgG,is produced indefinitely. The presence of IgM in the blood of the host is used to test for acute infection, whereas IgG indicates an infection sometime in the past.[153]IgG antibody is measured when tests forimmunityare carried out.[154]

Antibodies can continue to be an effective defence mechanism even after viruses have managed to gain entry to the host cell. A protein that is in cells, calledTRIM21,can attach to the antibodies on the surface of the virus particle. This primes the subsequent destruction of the virus by the enzymes of the cell'sproteosomesystem.[155]

Tworotaviruses:the one on the right is coated with antibodies that prevent its attachment to cells and infecting them.

A second defence of vertebrates against viruses is calledcell-mediated immunityand involves immune cells known asT cells.The body's cells constantly display short fragments of their proteins on the cell's surface, and, if a T cell recognises a suspicious viral fragment there, the host cell is destroyed by 'killer T' cells and the virus-specific T-cells proliferate. Cells such as themacrophageare specialists at thisantigen presentation.[156]The production ofinterferonis an important host defence mechanism. This is a hormone produced by the body when viruses are present. Its role in immunity is complex; it eventually stops the viruses from reproducing by killing the infected cell and its close neighbours.[157]

Not all virus infections produce a protective immune response in this way. HIV evades the immune system by constantly changing the amino acid sequence of the proteins on the surface of the virion. This is known as "escape mutation" as the viral epitopes escape recognition by the host immune response. These persistent viruses evade immune control by sequestration, blockade ofantigen presentation,cytokineresistance, evasion ofnatural killer cellactivities, escape fromapoptosis,andantigenic shift.[158]Other viruses, called 'neurotropic viruses', are disseminated by neural spread where the immune system may be unable to reach them due toimmune privilege.[159]

Prevention and treatment

Because viruses use vital metabolic pathways within host cells to replicate, they are difficult to eliminate without using drugs that cause toxic effects to host cells in general. The most effective medical approaches to viral diseases arevaccinationsto provide immunity to infection, andantiviral drugsthat selectively interfere with viral replication.

Vaccines

Vaccination is a cheap and effective way of preventing infections by viruses. Vaccines were used to prevent viral infections long before the discovery of the actual viruses. Their use has resulted in a dramatic decline in morbidity (illness) and mortality (death) associated with viral infections such aspolio,measles,mumpsandrubella.[160]Smallpoxinfections have been eradicated.[161]Vaccines are available to prevent over thirteen viral infections of humans,[162]and more are used to prevent viral infections of animals.[163]Vaccines can consist of live-attenuated or killed viruses, viral proteins (antigens), orRNA.[164][165]Live vaccines contain weakened forms of the virus, which do not cause the disease but, nonetheless, confer immunity. Such viruses are called attenuated. Live vaccines can be dangerous when given to people with a weak immunity (who are described asimmunocompromised), because in these people, the weakened virus can cause the original disease.[166]Biotechnology and genetic engineering techniques are used to produce subunit vaccines. These vaccines use only the capsid proteins of the virus. Hepatitis B vaccine is an example of this type of vaccine.[167]Subunit vaccines are safe forimmunocompromisedpatients because they cannot cause the disease.[168]Theyellow fever virus vaccine,a live-attenuated strain called 17D, is probably the safest and most effective vaccine ever generated.[169]

Antiviral drugs

The structure of the DNA baseguanosineand the antiviral drugacyclovir

Antiviral drugs are oftennucleoside analogues(fake DNA building-blocks), which viruses mistakenly incorporate into their genomes during replication.[170]The life-cycle of the virus is then halted because the newly synthesised DNA is inactive. This is because these analogues lack thehydroxylgroups, which, along withphosphorusatoms, link together to form the strong "backbone" of the DNA molecule. This is called DNAchain termination.[171]Examples of nucleoside analogues areaciclovirfor Herpes simplex virus infections andlamivudinefor HIV and hepatitis B virus infections. Aciclovir is one of the oldest and most frequently prescribed antiviral drugs.[172] Other antiviral drugs in use target different stages of the viral life cycle. HIV is dependent on a proteolytic enzyme called theHIV-1 proteasefor it to become fully infectious. There is a large class of drugs calledprotease inhibitorsthat inactivate this enzyme.[173]There are around thirteen classes of antiviral drugs each targeting different viruses or stages of viral replication.[170]

Hepatitis C is caused by an RNA virus. In 80% of people infected, the disease is chronic, and without treatment, they areinfectedfor the remainder of their lives. There are effective treatments that usedirect-acting antivirals.[174]The treatment of chroniccarriersof the hepatitis B virus has also been developed by using similar strategies that include lamivudine and other anti-viral drugs.[175]

Infection in other species

Viruses infect all cellular life and, although viruses occur universally, each cellular species has its own specific range that often infects only that species.[6]: 3 Some viruses, calledsatellites,can replicate only within cells that have already been infected by another virus.[30]

Animal viruses

Viruses are important pathogens of livestock. Diseases such as foot-and-mouth disease andbluetongueare caused by viruses.[176]Companion animals such as cats, dogs, and horses, if not vaccinated, are susceptible to serious viral infections.Canine parvovirusis caused by a small DNA virus and infections are often fatal in pups.[177]Like allinvertebrates,the honey bee is susceptible to many viral infections.[178]Most viruses co-exist harmlessly in their host and cause no signs or symptoms of disease.[6]: 4 

Plant viruses

Peppersinfected by mild mottle virus

There are many types of plant viruses, but often they cause only a loss ofyield,and it is not economically viable to try to control them. Plant viruses are often spread from plant to plant by organisms, known asvectors.These are usually insects, but some fungi,nematode worms,single-celled organisms,and parasitic plants are vectors.[179]When control of plant virus infections is considered economical, for perennial fruits, for example, efforts are concentrated on killing the vectors and removing alternate hosts such as weeds.[13]: 802 Plant viruses cannot infect humans and other animals because they can reproduce only in living plant cells.[13]: 799–807 

Originally from Peru, the potato has become a staple crop worldwide.[180]Thepotato virus Ycauses disease in potatoes and related species including tomatoes and peppers. In the 1980s, this virus acquired economical importance when it proved difficult to control in seed potato crops. Transmitted byaphids,this virus can reduce crop yields by up to 80 per cent, causing significant losses to potato yields.[181]

Plants have elaborate and effective defence mechanisms against viruses. One of the most effective is the presence of so-called resistance (R) genes. Each R gene confers resistance to a particular virus by triggering localised areas of cell death around the infected cell, which can often be seen with the unaided eye as large spots. This stops the infection from spreading.[182]RNA interference is also an effective defence in plants.[13]: 809 > When they are infected, plants often produce natural disinfectants that kill viruses, such assalicylic acid,nitric oxide,andreactive oxygen molecules.[183]

Plant virus particles or virus-like particles (VLPs) have applications in bothbiotechnologyandnanotechnology.The capsids of most plant viruses are simple and robust structures and can be produced in large quantities either by the infection of plants or by expression in a variety of heterologous systems. Plant virus particles can be modified genetically and chemically to encapsulate foreign material and can be incorporated into supramolecular structures for use in biotechnology.[184]

Bacterial viruses

Transmission electron micrograph of multiple bacteriophages attached to a bacterial cell wall

Bacteriophages are a common and diverse group of viruses and are the most abundant biological entity in aquatic environments—there are up to ten times more of these viruses in the oceans than there are bacteria,[185]reaching levels of 250,000,000 bacteriophages per millilitre of seawater.[186]These viruses infect specific bacteria by binding tosurface receptor moleculesand then entering the cell. Within a short amount of time, in some cases, just minutes, bacterialpolymerasestarts translating viral mRNA into protein. These proteins go on to become either new virions within the cell, helper proteins, which help assembly of new virions, or proteins involved in cell lysis. Viral enzymes aid in the breakdown of the cell membrane, and, in the case of theT4 phage,in just over twenty minutes after injection over three hundred phages could be released.[13]: 834–835 

The major way bacteria defend themselves from bacteriophages is by producing enzymes that destroy foreign DNA. These enzymes, calledrestriction endonucleases,cut up the viral DNA that bacteriophages inject into bacterial cells.[187]Bacteria also contain a system that usesCRISPRsequences to retain fragments of the genomes of viruses that the bacteria have come into contact with previously, which allows them to block the virus's replication through a form ofRNA interference.[188][189]This genetic system provides bacteria withacquired immunityto infection.[190]

Some bacteriophages are called "temperate"because they cause latent infections and do not immediately destroy their host cells. Instead, their DNA is incorporated with the host cell's as aprophage.These latent infections become productive when the prophage DNA is activated by stimuli such as changes in the environment.[191]The intestines of animals, including humans, contain temperate bacteriophages, which are activated by various stimuli including changes in diet and antibiotics.[192]Although first observed in bacteriophages, many other viruses are known to formprovirusesincluding HIV.[191][193]

Archaeal viruses

Some viruses replicate withinarchaea:these are DNA viruses with unusual and sometimes unique shapes.[4][55]These viruses have been studied in most detail in thethermophilicarchaea, particularly the ordersSulfolobalesandThermoproteales.[194]Defences against these viruses involve RNA interference fromrepetitive DNAsequences within archaean genomes that are related to the genes of the viruses.[195][196]Most archaea have CRISPR–Cas systems as an adaptive defence against viruses. These enable archaea to retain sections of viral DNA, which are then used to target and eliminate subsequent infections by the virus using a process similar to RNA interference.[197]

Role in aquatic ecosystems

Viruses are the most abundant biological entity in aquatic environments.[2]There are about ten million of them in a teaspoon of seawater.[198]Most of these viruses arebacteriophagesinfecting heterotrophic bacteria andcyanophagesinfecting cyanobacteria and they are essential to the regulation of saltwater and freshwater ecosystems.[199] Bacteriophages are harmless to plants and animals, and are essential to the regulation of marine and freshwater ecosystems[200]are important mortality agents ofphytoplankton,the base of thefoodchainin aquatic environments.[201]They infect and destroy bacteria in aquatic microbial communities, and are one of the most important mechanisms ofrecycling carbonandnutrient cyclingin marine environments. The organic molecules released from the dead bacterial cells stimulate fresh bacterial and algal growth, in a process known as theviral shunt.[202]In particular, lysis of bacteria by viruses has been shown to enhance nitrogen cycling and stimulate phytoplankton growth.[203]Viral activity may also affect thebiological pump,the process wherebycarbonissequesteredin the deep ocean.[204]

Microorganisms constitute more than 90% of the biomass in the sea. It is estimated that viruses kill approximately 20% of this biomass each day and that there are 10 to 15 times as many viruses in the oceans as there are bacteria and archaea.[205]Viruses are also major agents responsible for the destruction ofphytoplanktonincludingharmful algal blooms,[206] The number of viruses in the oceans decreases further offshore and deeper into the water, where there are fewer host organisms.[204]

In January 2018, scientists reported that 800 million viruses, mainly of marine origin, are deposited daily from theEarth'satmosphereonto every square meter of the planet's surface, as the result of a global atmospheric stream of viruses, circulating above the weather system but below the altitude of usual airline travel, distributing viruses around the planet.[207][208]

Like any organism,marine mammalsare susceptible to viral infections. In 1988 and 2002, thousands ofharbour sealswere killed in Europe byphocine distemper virus.[209]Many other viruses, includingcaliciviruses,herpesviruses,adenovirusesandparvoviruses,circulate in marine mammal populations.[204]

In December 2022, scientists reported the first observation ofvirovoryvia an experiment on pond water containingchlorovirus,which commonly infects green algae in freshwater environments. When all other microbial food sources were removed from the water, theciliateHalteriawas observed to have increased in number due to the active consumption of chlorovirus as a food source instead of its typicalbacterivorediet.[210][211]

Role in evolution

Viruses are an important natural means of transferring genes between different species, which increasesgenetic diversityand drives evolution.[9][212][213]It is thought that viruses played a central role in early evolution, before the diversification of thelast universal common ancestorinto bacteria, archaea and eukaryotes.[214]Viruses are still one of the largest reservoirs of unexplored genetic diversity on Earth.[204]

Applications

Life sciences and medicine

Scientist studying theH5N1influenza virus

Viruses are important to the study ofmolecularandcell biologyas they provide simple systems that can be used to manipulate and investigate the functions of cells.[26]: 8 The study and use of viruses have provided valuable information about aspects of cell biology.[215]For example, viruses have been useful in the study ofgeneticsand helped our understanding of the basic mechanisms ofmolecular genetics,such asDNA replication,transcription,RNA processing,translation,proteintransport, andimmunology.

Geneticists often use viruses asvectorsto introduce genes into cells that they are studying. This is useful for making the cell produce a foreign substance, or to study the effect of introducing a new gene into the genome. Similarly,virotherapyuses viruses as vectors to treat various diseases, as they can specifically target cells and DNA. It shows promising use in the treatment of cancer and ingene therapy.Eastern European scientists have usedphage therapyas an alternative to antibiotics for some time, and interest in this approach is increasing, because of the high level ofantibiotic resistancenow found in some pathogenic bacteria.[216] The expression of heterologous proteins by viruses is the basis of several manufacturing processes that are currently being used for the production of various proteins such as vaccineantigensand antibodies. Industrial processes have been recently developed using viral vectors and several pharmaceutical proteins are currently in pre-clinical and clinical trials.[217]

Virotherapy

Virotherapy involves the use of genetically modified viruses to treat diseases.[218]Viruses have been modified by scientists to reproduce in cancer cells and destroy them but not infect healthy cells.Talimogene laherparepvec(T-VEC), for example, is a modifiedherpes simplex virusthat has had a gene, which is required for viruses to replicate in healthy cells, deleted and replaced with a human gene (GM-CSF) that stimulates immunity. When this virus infects cancer cells, it destroys them and in doing so the presence the GM-CSF gene attractsdendritic cellsfrom the surrounding tissues of the body. The dendritic cells process the dead cancer cells and present components of them to other cells of theimmune system.[219]Having completed successfulclinical trials,the virus gained approval for the treatment ofmelanomain late 2015.[220]Viruses that have been reprogrammed to kill cancer cells are calledoncolytic viruses.[221]

Materials science and nanotechnology

From the viewpoint of a materials scientist, viruses can be regarded as organicnanoparticles.[222]Their surface carries specific tools that enable them to cross the barriers of their host cells. The size and shape of viruses and the number and nature of the functional groups on their surface are precisely defined. As such, viruses are commonly used in materials science as scaffolds for covalently linked surface modifications. A particular quality of viruses is that they can be tailored by directed evolution. The powerful techniques developed by life sciences are becoming the basis of engineering approaches towards nanomaterials, opening a wide range of applications far beyond biology and medicine.[223]Because of their size, shape, and well-defined chemical structures, viruses have been used as templates for organising materials on the nanoscale. Examples include the work at theNaval Research Laboratoryin Washington, D.C., usingCowpea mosaic virus(CPMV) particles to amplify signals inDNA microarraybased sensors. In this application, the virus particles separate thefluorescentdyesused for signalling to prevent the formation of non-fluorescentdimersthat act asquenchers.[224]Another example is the use of CPMV as a nanoscale breadboard for molecular electronics.[225]

Synthetic viruses

Many viruses can be synthesised de novo ( "from scratch" ). The first synthetic virus was created in 2002.[226]Although somewhat of a misconception, it is not the actual virus that is synthesised, but rather its DNA genome (in case of a DNA virus), or acDNAcopy of its genome (in case of RNA viruses). For many virus families the naked synthetic DNA or RNA (once enzymatically converted back from the synthetic cDNA) is infectious when introduced into a cell. That is, they contain all the necessary information to produce new viruses. This technology is now being used to investigate novel vaccine strategies.[227]The ability to synthesise viruses has far-reaching consequences, since viruses can no longer be regarded as extinct, as long as the information of their genome sequence is known andpermissivecells are available. As of June 2021, the full-length genome sequences of 11,464 different viruses, including smallpox, are publicly available in an online database maintained by theNational Institutes of Health.[228]

Weapons

The ability of viruses to cause devastating epidemics in human societies has led to the concern that viruses could be weaponised forbiological warfare.Further concern was raised by the successful recreation of the infamous1918 influenzavirus in a laboratory.[229] The smallpox virus devastated numerous societies throughout history before its eradication. There are only two centres in the world authorised by the WHO to keep stocks of smallpox virus: theState Research Center of Virology and Biotechnology VECTORin Russia and theCenters for Disease Control and Preventionin the United States.[230]It may be used as a weapon,[230]as the vaccine for smallpox sometimes had severe side-effects, it is no longer used routinely in any country. Thus, much of the modern human population has almost no established resistance to smallpox and would be vulnerable to the virus.[230]

See also

References

  1. ^Wu KJ (15 April 2020)."There are more viruses than stars in the universe. Why do only some infect us? – More than a quadrillion quadrillion individual viruses exist on Earth, but most are not poised to hop into humans. Can we find the ones that are?".National Geographic Society.Archived fromthe originalon 15 April 2020.Retrieved18 May2020.
  2. ^abcKoonin EV, Senkevich TG, Dolja VV (September 2006)."The ancient Virus World and evolution of cells".Biology Direct.1(1): 29.doi:10.1186/1745-6150-1-29.PMC1594570.PMID16984643.
  3. ^Zimmer C(26 February 2021)."The Secret Life of a Coronavirus - An oily, 100-nanometer-wide bubble of genes has killed more than two million people and reshaped the world. Scientists don't quite know what to make of it".The New York Times.Archived fromthe originalon 28 December 2021.Retrieved28 February2021.
  4. ^abLawrence CM, Menon S, Eilers BJ, Bothner B, Khayat R, Douglas T, et al. (May 2009)."Structural and functional studies of archaeal viruses".The Journal of Biological Chemistry.284(19): 12599–603.doi:10.1074/jbc.R800078200.PMC2675988.PMID19158076.
  5. ^Edwards RA, Rohwer F (June 2005). "Viral metagenomics".Nature Reviews. Microbiology.3(6): 504–10.doi:10.1038/nrmicro1163.PMID15886693.S2CID8059643.
  6. ^abcdefghijklmnDimmock NJ, Easton AJ, Leppard K (2007).Introduction to Modern Virology(6th ed.). Blackwell Publishing.ISBN978-1-4051-3645-7.
  7. ^abc"Virus Taxonomy: 2022 Release".talk.ictvonline.org.International Committee on Taxonomy of Viruses.Retrieved27 April2023.
  8. ^abBreitbart M,Rohwer F (June 2005). "Here a virus, there a virus, everywhere the same virus?".Trends in Microbiology.13(6): 278–84.doi:10.1016/j.tim.2005.04.003.PMID15936660.
  9. ^abCanchaya C, Fournous G, Chibani-Chennoufi S, Dillmann ML, Brüssow H (August 2003). "Phage as agents of lateral gene transfer".Current Opinion in Microbiology.6(4): 417–24.doi:10.1016/S1369-5274(03)00086-9.PMID12941415.
  10. ^abRybicki EP (1990). "The classification of organisms at the edge of life, or problems with virus systematics".South African Journal of Science.86:182–86.
  11. ^abKoonin EV, Starokadomskyy P (October 2016)."Are viruses alive? The replicator paradigm sheds decisive light on an old but misguided question".Studies in History and Philosophy of Biological and Biomedical Sciences.59:125–34.doi:10.1016/j.shpsc.2016.02.016.PMC5406846.PMID26965225.
  12. ^Robilotti E, Deresinski S, Pinsky BA (January 2015)."Norovirus".Clinical Microbiology Reviews.28(1): 134–64.doi:10.1128/CMR.00075-14.PMC4284304.PMID25567225.
  13. ^abcdefghijklmnopqrsShors T (2017).Understanding Viruses.Jones and Bartlett Publishers.ISBN978-1-284-02592-7.
  14. ^"Virus, n.".OED Online.Oxford University Press. March 2015.
  15. ^abHarper D (2011)."virus".The Online Etymology Dictionary.Retrieved19 December2014.
  16. ^"Virulent, adj.".OED Online.Oxford University Press. March 2015.
  17. ^Harper D (2011)."virulent".The Online Etymology Dictionary.Retrieved19 December2014.
  18. ^Buschard K, Thon R (2003). "Diabetic Animal Models". In Hau J, Van Hoosier Jr GL (eds.).Handbook of Laboratory Animal Science.Animal Models. Vol. II (2nd ed.). CRC Press. pp. 163, 166.
  19. ^William T. Stearn:Botanical Latin. History, Grammar, Syntax, Terminology and Vocabulary.David & Charles, 3rd ed., 1983. Quote: "Virus: virus (s.n. II),gen. sing.viri,nom. pl.vira,gen. pl.vīrorum (to be distinguished fromvirorum,of men). "
  20. ^Harper D (2011)."viral".The Online Etymology Dictionary.Retrieved19 December2014.
  21. ^Harper D (2011)."virion".The Online Etymology Dictionary.Retrieved19 December2014.
  22. ^Casjens S (2010). Mahy BW, Van Regenmortel MH (eds.).Desk Encyclopedia of General Virology.Boston: Academic Press. p. 167.ISBN978-0-12-375146-1.
  23. ^Iyer LM, Balaji S, Koonin EV, Aravind L (April 2006)."Evolutionary genomics of nucleo-cytoplasmic large DNA viruses".Virus Research.117(1): 156–84.doi:10.1016/j.virusres.2006.01.009.PMID16494962.
  24. ^abSanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R (October 2010)."Viral mutation rates".Journal of Virology.84(19): 9733–9748.doi:10.1128/JVI.00694-10.PMC2937809.PMID20660197.
  25. ^Krupovic M, Dolja VV, Koonin EV (July 2019)."Origin of viruses: primordial replicators recruiting capsids from hosts"(PDF).Nature Reviews. Microbiology.17(7): 449–58.doi:10.1038/s41579-019-0205-6.PMID31142823.S2CID256744818.
  26. ^abcdefghijklmnopqrstuCollier L, Balows A, Sussman M (1998). Mahy B, Collier LA (eds.).Topley and Wilson's Microbiology and Microbial Infections.Virology. Vol. 1 (9th ed.).ISBN0-340-66316-2.
  27. ^abcdefghMahy WJ, Regenmortel MH, eds. (2009).Desk Encyclopedia of General Virology.Oxford: Academic Press.ISBN978-0-12-375146-1.
  28. ^McClintock B (June 1950)."The origin and behavior of mutable loci in maize".Proceedings of the National Academy of Sciences of the United States of America.36(6): 344–55.Bibcode:1950PNAS...36..344M.doi:10.1073/pnas.36.6.344.PMC1063197.PMID15430309.
  29. ^Tsagris EM, Martínez de Alba AE, Gozmanova M, Kalantidis K (November 2008)."Viroids".Cellular Microbiology.10(11): 2168–79.doi:10.1111/j.1462-5822.2008.01231.x.PMID18764915.S2CID221581424.
  30. ^abLa Scola B, Desnues C, Pagnier I, Robert C, Barrassi L, Fournous G, et al. (September 2008). "The virophage as a unique parasite of the giant mimivirus".Nature.455(7209): 100–04.Bibcode:2008Natur.455..100L.doi:10.1038/nature07218.PMID18690211.S2CID4422249.
  31. ^Dimmock pp. 15–16
  32. ^Zerbini FM, Kitajima EW (September 2022)."From Contagium vivum fluidum to Riboviria: A Tobacco Mosaic Virus-Centric History of Virus Taxonomy".Biomolecules.12(10): 1363.doi:10.3390/biom12101363.PMC9599303.PMID36291572.
  33. ^Holmes EC (October 2007)."Viral evolution in the genomic age".PLOS Biology.5(10): e278.doi:10.1371/journal.pbio.0050278.PMC1994994.PMID17914905.
  34. ^Wimmer E, Mueller S, Tumpey TM, Taubenberger JK (December 2009)."Synthetic viruses: a new opportunity to understand and prevent viral disease".Nature Biotechnology.27(12): 1163–72.doi:10.1038/nbt.1593.PMC2819212.PMID20010599.
  35. ^Horn M (2008). "Chlamydiae as symbionts in eukaryotes".Annual Review of Microbiology.62:113–31.doi:10.1146/annurev.micro.62.081307.162818.PMID18473699.
  36. ^Ammerman NC, Beier-Sexton M, Azad AF (November 2008)."Laboratory maintenance of Rickettsia rickettsii".Current Protocols in Microbiology.11(1): 3A.5.1–3A.5.21.doi:10.1002/9780471729259.mc03a05s11.ISBN978-0471729259.PMC2725428.PMID19016440.
  37. ^Forterre, P. The virocell concept and environmental microbiology. ISME J 7, 233–236 (2013).https://doi.org/10.1038/ismej.2012.110
  38. ^DeLong JP, Al-Sammak MA, Al-Ameeli ZT, Dunigan DD, Edwards KF, Fuhrmann JJ, et al. (February 2022). "Towards an integrative view of virus phenotypes".Nature Reviews. Microbiology.20(2): 83–94.doi:10.1038/s41579-021-00612-w.PMID34522049.
  39. ^Krasner R (2014).The microbial challenge: a public health perspective.Burlington, Mass: Jones & Bartlett Learning.ISBN978-1-4496-7375-8.OCLC794228026.
  40. ^Kiselev NA, Sherman MB, Tsuprun VL (1990). "Negative staining of proteins".Electron Microscopy Reviews.3(1): 43–72.doi:10.1016/0892-0354(90)90013-I.PMID1715774.
  41. ^Caspar DL, Klug A (1962). "Physical principles in the construction of regular viruses".Cold Spring Harbor Symposia on Quantitative Biology.27:1–24.doi:10.1101/sqb.1962.027.001.005.PMID14019094.
  42. ^Crick FH, Watson JD (March 1956). "Structure of small viruses".Nature.177(4506): 473–75.Bibcode:1956Natur.177..473C.doi:10.1038/177473a0.PMID13309339.S2CID5740221.
  43. ^Falvo MR, Washburn S, Superfine R, Finch M, Brooks FP, Chi V, et al. (March 1997)."Manipulation of individual viruses: friction and mechanical properties".Biophysical Journal.72(3): 1396–403.Bibcode:1997BpJ....72.1396F.doi:10.1016/S0006-3495(97)78786-1.PMC1184522.PMID9138585.
  44. ^Kuznetsov YG, Malkin AJ, Lucas RW, Plomp M, McPherson A (September 2001)."Imaging of viruses by atomic force microscopy".The Journal of General Virology.82(Pt 9): 2025–34.doi:10.1099/0022-1317-82-9-2025.PMID11514711.
  45. ^Straus SK, Bo HE (2018). "Filamentous Bacteriophage Proteins and Assembly".Virus Protein and Nucleoprotein Complexes.Subcellular Biochemistry. Vol. 88. pp. 261–79.doi:10.1007/978-981-10-8456-0_12.ISBN978-981-10-8455-3.PMID29900501.
  46. ^Wilson DP (2016)."Protruding Features of Viral Capsids Are Clustered on Icosahedral Great Circles".PLOS ONE.11(4): e0152319.Bibcode:2016PLoSO..1152319W.doi:10.1371/journal.pone.0152319.PMC4821576.PMID27045511.
  47. ^Casens S (2009).Desk Encyclopedia of General Virology.Boston: Academic Press. pp. 167–74.ISBN978-0-12-375146-1.
  48. ^Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. (September 2020)."Coronavirus Disease 2019-COVID-19".Clinical Microbiology Reviews.33(4).doi:10.1128/CMR.00028-20.PMC7405836.PMID32580969.
  49. ^Rossmann MG, Mesyanzhinov VV, Arisaka F, Leiman PG (April 2004). "The bacteriophage T4 DNA injection machine".Current Opinion in Structural Biology.14(2): 171–80.doi:10.1016/j.sbi.2004.02.001.PMID15093831.
  50. ^Long GW, Nobel J, Murphy FA, Herrmann KL, Lourie B (September 1970)."Experience with electron microscopy in the differential diagnosis of smallpox".Applied Microbiology.20(3): 497–504.doi:10.1128/AEM.20.3.497-504.1970.PMC376966.PMID4322005.
  51. ^Suzan-Monti M, La Scola B, Raoult D (April 2006). "Genomic and evolutionary aspects of Mimivirus".Virus Research.117(1): 145–55.doi:10.1016/j.virusres.2005.07.011.PMID16181700.
  52. ^Arslan D, Legendre M, Seltzer V, Abergel C, Claverie JM (October 2011)."Distant Mimivirus relative with a larger genome highlights the fundamental features of Megaviridae".Proceedings of the National Academy of Sciences of the United States of America.108(42): 17486–91.Bibcode:2011PNAS..10817486A.doi:10.1073/pnas.1110889108.PMC3198346.PMID21987820.
  53. ^abPhilippe N, Legendre M, Doutre G, Couté Y, Poirot O, Lescot M, et al. (July 2013)."Pandoraviruses: amoeba viruses with genomes up to 2.5 Mb reaching that of parasitic eukaryotes"(PDF).Science.341(6143): 281–86.Bibcode:2013Sci...341..281P.doi:10.1126/science.1239181.PMID23869018.S2CID16877147.
  54. ^Brandes N, Linial M (April 2019)."Giant Viruses-Big Surprises".Viruses.11(5): 404.doi:10.3390/v11050404.PMC6563228.PMID31052218.
  55. ^abPrangishvili D, Forterre P, Garrett RA (November 2006). "Viruses of the Archaea: a unifying view".Nature Reviews. Microbiology.4(11): 837–48.doi:10.1038/nrmicro1527.PMID17041631.S2CID9915859.
  56. ^"NCBI Viral Genome database".ncbi.nlm.nih.gov.Retrieved15 January2017.
  57. ^Pennisi E(March 2011). "Microbiology. Going viral: exploring the role of viruses in our bodies".Science.331(6024): 1513.Bibcode:2011Sci...331.1513P.doi:10.1126/science.331.6024.1513.PMID21436418.
  58. ^Shi M, Lin XD, Tian JH, Chen LJ, Chen X, Li CX, et al. (December 2016). "Redefining the invertebrate RNA virosphere".Nature.540(7634): 539–43.Bibcode:2016Natur.540..539S.doi:10.1038/nature20167.PMID27880757.S2CID1198891.
  59. ^Saunders VA, Carter J (2007).Virology: principles and applications.Chichester: John Wiley & Sons. p. 72.ISBN978-0-470-02387-7.
  60. ^Belyi VA, Levine AJ, Skalka AM (December 2010)."Sequences from ancestral single-stranded DNA viruses in vertebrate genomes: the parvoviridae and circoviridae are more than 40 to 50 million years old".Journal of Virology.84(23): 12458–62.doi:10.1128/JVI.01789-10.PMC2976387.PMID20861255.
  61. ^Brandes N, Linial M (May 2016)."Gene overlapping and size constraints in the viral world".Biology Direct.11(1): 26.doi:10.1186/s13062-016-0128-3.PMC4875738.PMID27209091.
  62. ^Pressing J, Reanney DC (1984)."Divided genomes and intrinsic noise".Journal of Molecular Evolution.20(2): 135–46.Bibcode:1984JMolE..20..135P.doi:10.1007/BF02257374.PMC7087551.PMID6433032.
  63. ^Duffy S, Holmes EC (June 2009)."Validation of high rates of nucleotide substitution in geminiviruses: phylogenetic evidence from East African cassava mosaic viruses".The Journal of General Virology.90(Pt 6): 1539–47.doi:10.1099/vir.0.009266-0.PMC4091138.PMID19264617.
  64. ^Sandbulte MR, Westgeest KB, Gao J, Xu X, Klimov AI, Russell CA, et al. (December 2011)."Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses".Proceedings of the National Academy of Sciences of the United States of America.108(51): 20748–53.Bibcode:2011PNAS..10820748S.doi:10.1073/pnas.1113801108.PMC3251064.PMID22143798.
  65. ^Moss RB, Davey RT, Steigbigel RT, Fang F (June 2010)."Targeting pandemic influenza: a primer on influenza antivirals and drug resistance".The Journal of Antimicrobial Chemotherapy.65(6): 1086–93.doi:10.1093/jac/dkq100.PMID20375034.
  66. ^Hampson AW, Mackenzie JS (November 2006). "The influenza viruses".The Medical Journal of Australia.185(S10): S39–43.doi:10.5694/j.1326-5377.2006.tb00705.x.PMID17115950.S2CID17069567.
  67. ^Metzner KJ (December 2006). "Detection and significance of minority quasispecies of drug-resistant HIV-1".Journal of HIV Therapy.11(4): 74–81.PMID17578210.
  68. ^Goudsmit, Jaap.Viral Sex.Oxford Univ Press, 1998.ISBN978-0-19-512496-5
  69. ^Worobey M, Holmes EC (October 1999)."Evolutionary aspects of recombination in RNA viruses".The Journal of General Virology.80(10): 2535–43.doi:10.1099/0022-1317-80-10-2535.PMID10573145.
  70. ^Lukashev AN (2005). "Role of recombination in evolution of enteroviruses".Reviews in Medical Virology.15(3): 157–67.doi:10.1002/rmv.457.PMID15578739.S2CID26000112.
  71. ^Umene K (July 1999). "Mechanism and application of genetic recombination in herpesviruses".Reviews in Medical Virology.9(3): 171–82.doi:10.1002/(SICI)1099-1654(199907/09)9:3<171::AID-RMV243>3.0.CO;2-A.PMID10479778.S2CID43110533.
  72. ^Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, et al. (June 2016)."Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses".Trends in Microbiology.24(6): 490–502.doi:10.1016/j.tim.2016.03.003.PMC7125511.PMID27012512.
  73. ^Barr JN, Fearns R (June 2010). "How RNA viruses maintain their genome integrity".The Journal of General Virology.91(Pt 6): 1373–87.doi:10.1099/vir.0.020818-0.PMID20335491.
  74. ^Freed EO (August 2015)."HIV-1 assembly, release and maturation".Nature Reviews. Microbiology.13(8): 484–96.doi:10.1038/nrmicro3490.PMC6936268.PMID26119571.
  75. ^Yin J, Redovich J (June 2018)."Kinetic Modeling of Virus Growth in Cells".Microbiology and Molecular Biology Reviews.82(2).doi:10.1128/MMBR.00066-17.PMC5968458.PMID29592895.
  76. ^Más V, Melero JA (2013). "Entry of Enveloped Viruses into Host Cells: Membrane Fusion".Structure and Physics of Viruses.Subcellular Biochemistry. Vol. 68. pp. 467–87.doi:10.1007/978-94-007-6552-8_16.ISBN978-94-007-6551-1.PMC7121288.PMID23737062.
  77. ^Boevink P, Oparka KJ (August 2005)."Virus-host interactions during movement processes".Plant Physiology.138(4): 1815–21.doi:10.1104/pp.105.066761.PMC1183373.PMID16172094.
  78. ^Blaas D (May 2016)."Viral entry pathways: the example of common cold viruses".Wiener Medizinische Wochenschrift.166(7–8): 211–26.doi:10.1007/s10354-016-0461-2.PMC4871925.PMID27174165.
  79. ^Isomura H, Stinski MF (February 2013). "Coordination of late gene transcription of human cytomegalovirus with viral DNA synthesis: recombinant viruses as potential therapeutic vaccine candidates".Expert Opinion on Therapeutic Targets.17(2): 157–66.doi:10.1517/14728222.2013.740460.PMID23231449.S2CID11448687.
  80. ^Barman S, Ali A, Hui EK, Adhikary L, Nayak DP (September 2001). "Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses".Virus Research.77(1): 61–69.doi:10.1016/S0168-1702(01)00266-0.PMID11451488.
  81. ^Staginnus C, Richert-Pöggeler KR (October 2006). "Endogenous pararetroviruses: two-faced travelers in the plant genome".Trends in Plant Science.11(10): 485–91.Bibcode:2006TPS....11..485S.doi:10.1016/j.tplants.2006.08.008.PMID16949329.
  82. ^Roulston A, Marcellus RC, Branton PE (1999). "Viruses and apoptosis".Annual Review of Microbiology.53:577–628.doi:10.1146/annurev.micro.53.1.577.PMID10547702.
  83. ^Alwine JC (2008). "Modulation of Host Cell Stress Responses by Human Cytomegalovirus".Human Cytomegalovirus.Current Topics in Microbiology and Immunology. Vol. 325. pp. 263–79.doi:10.1007/978-3-540-77349-8_15.ISBN978-3-540-77348-1.PMID18637511.
  84. ^Barozzi P, Potenza L, Riva G, Vallerini D, Quadrelli C, Bosco R, et al. (December 2007). "B cells and herpesviruses: a model of lymphoproliferation".Autoimmunity Reviews.7(2): 132–36.doi:10.1016/j.autrev.2007.02.018.PMID18035323.
  85. ^Subramanya D, Grivas PD (November 2008). "HPV and cervical cancer: updates on an established relationship".Postgraduate Medicine.120(4): 7–13.doi:10.3810/pgm.2008.11.1928.PMID19020360.S2CID1399003.
  86. ^Sinclair J (March 2008). "Human cytomegalovirus: Latency and reactivation in the myeloid lineage".Journal of Clinical Virology.41(3): 180–85.doi:10.1016/j.jcv.2007.11.014.PMID18164651.
  87. ^Jordan MC, Jordan GW, Stevens JG, Miller G (June 1984). "Latent herpesviruses of humans".Annals of Internal Medicine.100(6): 866–80.doi:10.7326/0003-4819-100-6-866.PMID6326635.
  88. ^Sissons JG, Bain M, Wills MR (February 2002). "Latency and reactivation of human cytomegalovirus".The Journal of Infection.44(2): 73–77.doi:10.1053/jinf.2001.0948.PMID12076064.
  89. ^Crawford DH (2011)."Chapter 2: Viruses are Everywhere".Viruses: A Very Short Introduction.Oxford University Press, US. p.16.ISBN978-0-19-957485-8.
  90. ^Baggesen DL, Sørensen G, Nielsen EM, Wegener HC (January 2010)."Phage typing of Salmonella Typhimurium – is it still a useful tool for surveillance and outbreak investigation?".Euro Surveillance.15(4): 19471.PMID20122382.Retrieved19 December2014.
  91. ^Parker MT (September 2016)."An Ecological Framework of the Human Virome Provides Classification of Current Knowledge and Identifies Areas of Forthcoming Discovery".The Yale Journal of Biology and Medicine.89(3): 339–51.PMC5045143.PMID27698618.
  92. ^Woolhouse M, Scott F, Hudson Z, Howey R, Chase-Topping M (October 2012)."Human viruses: discovery and emergence".Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.367(1604): 2864–71.doi:10.1098/rstb.2011.0354.PMC3427559.PMID22966141.
  93. ^abAshour HM, Elkhatib WF, Rahman MM, Elshabrawy HA (March 2020)."Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks".Pathogens.9(3): 186.doi:10.3390/pathogens9030186.PMC7157630.PMID32143502.
  94. ^Lwoff A, Horne RW, Tournier P (June 1962). "[A virus system]".Comptes Rendus Hebdomadaires des Séances de l'Académie des Sciences(in French).254:4225–27.PMID14467544.
  95. ^Lwoff A, Horne R, Tournier P (1962). "A system of viruses".Cold Spring Harbor Symposia on Quantitative Biology.27:51–55.doi:10.1101/sqb.1962.027.001.008.PMID13931895.
  96. ^Fauquet CM, Fargette D (August 2005)."International Committee on Taxonomy of Viruses and the 3,142 unassigned species".Virology Journal.2:64.doi:10.1186/1743-422X-2-64.PMC1208960.PMID16105179.
  97. ^International Committee on Taxonomy of Viruses Executive Committee (May 2020)."The New Scope of Virus Taxonomy: Partitioning the Virosphere Into 15 Hierarchical Ranks".Nat Microbiol.5(5): 668–74.doi:10.1038/s41564-020-0709-x.PMC7186216.PMID32341570.
  98. ^Khan MK, Alam MM (July 2021). "Norovirus Gastroenteritis Outbreaks, Genomic Diversity and Evolution: An Overview".Mymensingh Medical Journal.30(3): 863–73.PMID34226482.
  99. ^Eberle J, Gürtler L (2012)."HIV types, groups, subtypes and recombinant forms: errors in replication, selection pressure and quasispecies".Intervirology.55(2): 79–83.doi:10.1159/000331993.PMID22286874.S2CID5642060.
  100. ^International Committee on Taxonomy of Viruses Executive Committee (May 2020)."The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks".Nature Microbiology.5(5): 668–674.doi:10.1038/s41564-020-0709-x.PMC7186216.PMID32341570.
  101. ^Delwart EL (2007)."Viral metagenomics".Reviews in Medical Virology.17(2): 115–131.doi:10.1002/rmv.532.PMC7169062.PMID17295196.
  102. ^Temin HM, Baltimore D (1972). "RNA-directed DNA synthesis and RNA tumor viruses".Advances in Virus Research.17:129–86.doi:10.1016/S0065-3527(08)60749-6.ISBN978-0120398171.PMID4348509.
  103. ^Baltimore D (1974). "The strategy of RNA viruses".Harvey Lectures.70 Series.70:57–74.PMID4377923.
  104. ^van Regenmortel MH, Mahy BW (January 2004)."Emerging issues in virus taxonomy".Emerging Infectious Diseases.10(1): 8–13.doi:10.3201/eid1001.030279.PMC3322749.PMID15078590.
  105. ^Mayo MA (1999)."Developments in plant virus taxonomy since the publication of the 6th ICTV Report. International Committee on Taxonomy of Viruses".Archives of Virology.144(8): 1659–66.doi:10.1007/s007050050620.PMID10486120.S2CID33422303.
  106. ^de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (June 2004). "Classification of papillomaviruses".Virology.324(1): 17–27.doi:10.1016/j.virol.2004.03.033.PMID15183049.
  107. ^Fisher B, Harvey RP, Champe PC (2007). "Chapter 33 (Disease summaries)".Lippincott's Illustrated Reviews: Microbiology.Lippincott's Illustrated Reviews Series. Hagerstwon, MD: Lippincott Williams & Wilkins. pp. 367–392.ISBN978-0-7817-8215-9.
  108. ^Komaroff AL (December 2006). "Is human herpesvirus-6 a trigger for chronic fatigue syndrome?".Journal of Clinical Virology.37(Suppl 1): S39–46.doi:10.1016/S1386-6532(06)70010-5.PMID17276367.
  109. ^Chen CH, Chiu YL, Wei FC, Koong FJ, Liu HC, Shaw CK, et al. (January 1999)."High seroprevalence of Borna virus infection in schizophrenic patients, family members and mental health workers in Taiwan".Molecular Psychiatry.4(1): 33–38.doi:10.1038/sj.mp.4000484.PMID10089006.S2CID19830976.
  110. ^Margolis TP, Elfman FL, Leib D, Pakpour N, Apakupakul K, Imai Y, et al. (October 2007)."Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia".Journal of Virology.81(20): 11069–74.doi:10.1128/JVI.00243-07.PMC2045564.PMID17686862.
  111. ^Whitley RJ, Roizman B (May 2001). "Herpes simplex virus infections".Lancet.357(9267): 1513–18.doi:10.1016/S0140-6736(00)04638-9.PMID11377626.S2CID9854903.
  112. ^Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, et al. (May 2007). "Herpesvirus latency confers symbiotic protection from bacterial infection".Nature.447(7142): 326–29.Bibcode:2007Natur.447..326B.doi:10.1038/nature05762.PMID17507983.S2CID4425405.
  113. ^Bertoletti A, Gehring A (October 2007). "Immune response and tolerance during chronic hepatitis B virus infection".Hepatology Research.37(Suppl 3): S331–38.doi:10.1111/j.1872-034X.2007.00221.x.PMID17931183.S2CID13386004.
  114. ^Rodrigues C, Deshmukh M, Jacob T, Nukala R, Menon S, Mehta A (2001). "Significance of HBV DNA by PCR over serological markers of HBV in acute and chronic patients".Indian Journal of Medical Microbiology.19(3): 141–44.PMID17664817.
  115. ^Nguyen VT, McLaws ML, Dore GJ (December 2007). "Highly endemic hepatitis B infection in rural Vietnam".Journal of Gastroenterology and Hepatology.22(12): 2093–100.doi:10.1111/j.1440-1746.2007.05010.x.PMID17645465.S2CID29885790.
  116. ^Fowler MG, Lampe MA, Jamieson DJ, Kourtis AP, Rogers MF (September 2007)."Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions".American Journal of Obstetrics and Gynecology.197(3 Suppl): S3–9.doi:10.1016/j.ajog.2007.06.048.PMID17825648.
  117. ^Sauerbrei A, Wutzler P (December 2000). "The congenital varicella syndrome".Journal of Perinatology.20(8 Pt 1): 548–54.doi:10.1038/sj.jp.7200457.PMID11190597.S2CID7973561.
  118. ^abAntonovics J, Wilson AJ, Forbes MR, Hauffe HC, Kallio ER, Leggett HC, et al. (May 2017)."The evolution of transmission mode".Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.372(1719).doi:10.1098/rstb.2016.0083.PMC5352810.PMID28289251.
  119. ^Garnett GP (February 2005)."Role of herd immunity in determining the effect of vaccines against sexually transmitted disease".The Journal of Infectious Diseases.191(Suppl 1): S97–106.doi:10.1086/425271.PMID15627236.
  120. ^Platonov AE (2006). "[The influence of weather conditions on the epidemiology of vector-borne diseases by the example of West Nile fever in Russia]".Vestnik Rossiiskoi Akademii Meditsinskikh Nauk(in Russian) (2): 25–29.PMID16544901.
  121. ^Jewell CP, Keeling MJ, Roberts GO (December 2009)."Predicting undetected infections during the 2007 foot-and-mouth disease outbreak".Journal of the Royal Society, Interface.6(41): 1145–51.doi:10.1098/rsif.2008.0433.PMC2817150.PMID19091686.
  122. ^Patterson KD, Pyle GF (1991). "The geography and mortality of the 1918 influenza pandemic".Bulletin of the History of Medicine.65(1): 4–21.PMID2021692.
  123. ^Johnson NP, Mueller J (2002). "Updating the accounts: global mortality of the 1918-1920" Spanish "influenza pandemic".Bulletin of the History of Medicine.76(1): 105–15.doi:10.1353/bhm.2002.0022.PMID11875246.S2CID22974230.
  124. ^Eisinger RW, Fauci AS (March 2018)."1".Emerging Infectious Diseases.24(3): 413–16.doi:10.3201/eid2403.171797.PMC5823353.PMID29460740.
  125. ^Qin Y, Zhao MJ, Tan YY, Li XQ, Zheng JD, Peng ZB, et al. (August 2018). "[History of influenza pandemics in China during the past century]".Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi(in Chinese).39(8): 1028–31.doi:10.3760/cma.j.issn.0254-6450.2018.08.003.PMID30180422.
  126. ^Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, et al. (February 1999)."Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes".Nature.397(6718): 436–41.Bibcode:1999Natur.397..436G.doi:10.1038/17130.PMID9989410.S2CID4432185.
  127. ^"Fact Sheet"(PDF).UNAIDS.org.2018.Retrieved12 December2019.
  128. ^"UN AIDS DATA2019".UNAIDS.org.2019.Retrieved5 December2019.
  129. ^Mawar N, Saha S, Pandit A, Mahajan U (December 2005)."The third phase of HIV pandemic: social consequences of HIV/AIDS stigma & discrimination & future needs"(PDF).The Indian Journal of Medical Research.122(6): 471–84.PMID16517997.Archived fromthe original(PDF)on 4 March 2016.Retrieved19 December2014.
  130. ^"Status of the global HIV epidemic"(PDF).UNAIDS. 2008. Archived fromthe original(PDF)on 22 November 2015.Retrieved19 December2014.
  131. ^Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA, et al. (July 2006)."Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola".Journal of Virology.80(13): 6497–516.doi:10.1128/JVI.00069-06.PMC1488971.PMID16775337.
  132. ^"World Health Organisation report, 24 September 2014"(PDF).
  133. ^"Virology Journal".Virology Journal.
  134. ^Weiss SR, Leibowitz JL (2011).Coronavirus pathogenesis.Advances in Virus Research. Vol. 81. pp. 85–164.doi:10.1016/B978-0-12-385885-6.00009-2.ISBN978-0-12-385885-6.PMC7149603.PMID22094080.
  135. ^Wong AT, Chen H, Liu SH, Hsu EK, Luk KS, Lai CK, et al. (May 2017)."From SARS to Avian Influenza Preparedness in Hong Kong".Clinical Infectious Diseases.64(suppl_2): S98–S104.doi:10.1093/cid/cix123.PMID28475794.
  136. ^Deng SQ, Peng HJ (February 2020)."Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China".Journal of Clinical Medicine.9(2): 575.doi:10.3390/jcm9020575.PMC7074453.PMID32093211.
  137. ^Han Q, Lin Q, Jin S, You L (April 2020)."Coronavirus 2019-nCoV: A brief perspective from the front line".The Journal of Infection.80(4): 373–77.doi:10.1016/j.jinf.2020.02.010.PMC7102581.PMID32109444.
  138. ^Londoño E, Ortiz A (16 March 2020)."Coronavirus Travel Restrictions, Across the Globe".The New York Times.
  139. ^"US takes more big pandemic response steps; Europe COVID-19 cases soar".CIDRAP.15 March 2020.
  140. ^Einstein MH, Schiller JT, Viscidi RP, Strickler HD, Coursaget P, Tan T, et al. (June 2009). "Clinician's guide to human papillomavirus immunology: knowns and unknowns".The Lancet. Infectious Diseases.9(6): 347–56.doi:10.1016/S1473-3099(09)70108-2.PMID19467474.
  141. ^Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, et al. (October 2008)."T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus".Proceedings of the National Academy of Sciences of the United States of America.105(42): 16272–77.Bibcode:2008PNAS..10516272S.doi:10.1073/pnas.0806526105.PMC2551627.PMID18812503.
  142. ^Pulitzer MP, Amin BD, Busam KJ (May 2009). "Merkel cell carcinoma: review".Advances in Anatomic Pathology.16(3): 135–44.doi:10.1097/PAP.0b013e3181a12f5a.PMID19395876.S2CID36110778.
  143. ^Koike K (June 2007). "Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways".Journal of Gastroenterology and Hepatology.22(Suppl 1): S108–11.doi:10.1111/j.1440-1746.2006.04669.x.PMID17567457.S2CID25399220.
  144. ^Hu J, Ludgate L (2007). "HIV–HBV and HIV–HCV Coinfection and Liver Cancer Development".Aids-Associated Viral Oncogenesis.Cancer Treatment and Research. Vol. 133. pp. 241–52.doi:10.1007/978-0-387-46816-7_9.ISBN978-0-387-46804-4.PMID17672044.
  145. ^Bellon M, Nicot C (2007). "Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia".Cancer Genomics & Proteomics.4(1): 21–25.PMID17726237.
  146. ^Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (September 2007). "Human papillomavirus and cervical cancer".Lancet.370(9590): 890–907.doi:10.1016/S0140-6736(07)61416-0.PMID17826171.S2CID20196938.
  147. ^Klein E, Kis LL, Klein G (February 2007)."Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions".Oncogene.26(9): 1297–305.doi:10.1038/sj.onc.1210240.PMID17322915.
  148. ^Zur Hausen H (July 2008)."Novel human polyomaviruses – re-emergence of a well known virus family as possible human carcinogens".International Journal of Cancer.123(2): 247–50.doi:10.1002/ijc.23620.PMID18449881.S2CID9482506.
  149. ^Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walters P (2002).Molecular Biology of the Cell(4th ed.). New York and London: Garland Science.ISBN0-8153-3218-1.
  150. ^Ding SW, Voinnet O (August 2007)."Antiviral immunity directed by small RNAs".Cell.130(3): 413–26.doi:10.1016/j.cell.2007.07.039.PMC2703654.PMID17693253.
  151. ^Patton JT, Vasquez-Del Carpio R, Spencer E (2004). "Replication and transcription of the rotavirus genome".Current Pharmaceutical Design.10(30): 3769–77.doi:10.2174/1381612043382620.PMID15579070.
  152. ^Jayaram H, Estes MK, Prasad BV (April 2004). "Emerging themes in rotavirus cell entry, genome organization, transcription and replication".Virus Research.101(1): 67–81.doi:10.1016/j.virusres.2003.12.007.PMID15010218.
  153. ^Greer S, Alexander GJ (December 1995). "Viral serology and detection".Baillière's Clinical Gastroenterology.9(4): 689–721.doi:10.1016/0950-3528(95)90057-8.PMID8903801.
  154. ^Matter L, Kogelschatz K, Germann D (April 1997)."Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations".The Journal of Infectious Diseases.175(4): 749–55.doi:10.1086/513967.PMID9086126.
  155. ^Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC (November 2010)."Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)".Proceedings of the National Academy of Sciences of the United States of America.107(46): 19985–90.Bibcode:2010PNAS..10719985M.doi:10.1073/pnas.1014074107.PMC2993423.PMID21045130.
  156. ^Cascalho M, Platt JL (2007). "Novel functions of B cells".Critical Reviews in Immunology.27(2): 141–51.doi:10.1615/critrevimmunol.v27.i2.20.PMID17725500.
  157. ^Le Page C, Génin P, Baines MG, Hiscott J (2000). "Interferon activation and innate immunity".Reviews in Immunogenetics.2(3): 374–86.PMID11256746.
  158. ^Hilleman MR (October 2004)."Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections".Proceedings of the National Academy of Sciences of the United States of America.101(Suppl 2): 14560–66.Bibcode:2004PNAS..10114560H.doi:10.1073/pnas.0404758101.PMC521982.PMID15297608.
  159. ^Libbey JE, Fujinami RS (2014). "Adaptive immune response to viral infections in the central nervous system".Neurovirology.Handbook of Clinical Neurology. Vol. 123. pp. 225–47.doi:10.1016/B978-0-444-53488-0.00010-9.ISBN978-0444534880.PMC4370180.PMID25015488.
  160. ^Asaria P, MacMahon E (October 2006)."Measles in the United Kingdom: can we eradicate it by 2010?".BMJ.333(7574): 890–95.doi:10.1136/bmj.38989.445845.7C.PMC1626346.PMID17068034.
  161. ^Lane JM (2006). "Mass vaccination and surveillance/containment in the eradication of smallpox".Mass Vaccination: Global Aspects — Progress and Obstacles.Current Topics in Microbiology and Immunology. Vol. 304. pp. 17–29.doi:10.1007/3-540-36583-4_2.ISBN978-3-540-29382-8.PMC7120753.PMID16989262.
  162. ^Arvin AM, Greenberg HB (January 2006)."New viral vaccines".Virology.344(1): 240–49.doi:10.1016/j.virol.2005.09.057.PMID16364754.
  163. ^Pastoret PP, Schudel AA, Lombard M (August 2007). "Conclusions--future trends in veterinary vaccinology".Revue Scientifique et Technique.26(2): 489–94, 495–501, 503–09.doi:10.20506/rst.26.2.1759.PMID17892169.
  164. ^Palese P(January 2006)."Making better influenza virus vaccines?".Emerging Infectious Diseases.12(1): 61–65.doi:10.3201/eid1201.051043.PMC3291403.PMID16494719.
  165. ^Anand P, Stahel VP (May 2021)."Review the safety of Covid-19 mRNA vaccines: a review".Patient Safety in Surgery.15(1): 20.doi:10.1186/s13037-021-00291-9.PMC8087878.PMID33933145.
  166. ^Thomssen R (1975). "Live attenuated versus killed virus vaccines".Monographs in Allergy.9:155–76.PMID1090805.
  167. ^McLean AA (1986). "Development of vaccines against hepatitis A and hepatitis B".Reviews of Infectious Diseases.8(4): 591–98.doi:10.1093/clinids/8.4.591.PMID3018891.
  168. ^Casswall TH, Fischler B (October 2005). "Vaccination of the immunocompromised child".Expert Review of Vaccines.4(5): 725–38.doi:10.1586/14760584.4.5.725.PMID16221073.S2CID40821818.
  169. ^Barnett ED, Wilder-Smith A, Wilson ME (July 2008). "Yellow fever vaccines and international travelers".Expert Review of Vaccines.7(5): 579–87.doi:10.1586/14760584.7.5.579.PMID18564013.S2CID19352868.
  170. ^abDe Clercq E, Li G (July 2016)."Approved Antiviral Drugs over the Past 50 Years".Clinical Microbiology Reviews.29(3): 695–747.doi:10.1128/CMR.00102-15.PMC4978613.PMID27281742.
  171. ^Magden J, Kääriäinen L, Ahola T (March 2005)."Inhibitors of virus replication: recent developments and prospects".Applied Microbiology and Biotechnology.66(6): 612–21.doi:10.1007/s00253-004-1783-3.PMC7082807.PMID15592828.
  172. ^Mindel A, Sutherland S (September 1983). "Genital herpes - the disease and its treatment including intravenous acyclovir".The Journal of Antimicrobial Chemotherapy.12(Suppl B): 51–59.doi:10.1093/jac/12.suppl_b.51.PMID6355051.
  173. ^Palmisano L, Vella S (2011). "A brief history of antiretroviral therapy of HIV infection: success and challenges".Annali dell'Istituto Superiore di Sanità.47(1): 44–48.doi:10.4415/ANN_11_01_10.PMID21430338.
  174. ^Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS (May 2017)."Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review".Annals of Internal Medicine.166(9): 637–48.doi:10.7326/M16-2575.PMC5486987.PMID28319996.
  175. ^Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G (March 2020)."Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy".Clinical Microbiology Reviews.33(2).doi:10.1128/CMR.00046-19.PMC7048015.PMID32102898.
  176. ^Goris N, Vandenbussche F, De Clercq K (April 2008). "Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock".Antiviral Research.78(1): 170–78.doi:10.1016/j.antiviral.2007.10.003.PMID18035428.
  177. ^Carmichael LE (2005). "An annotated historical account of canine parvovirus".Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health.52(7–8): 303–11.doi:10.1111/j.1439-0450.2005.00868.x.PMID16316389.
  178. ^Chen Y, Zhao Y, Hammond J, Hsu HT, Evans J, Feldlaufer M (October–November 2004)."Multiple virus infections in the honey bee and genome divergence of honey bee viruses".Journal of Invertebrate Pathology.87(2–3): 84–93.Bibcode:2004JInvP..87...84C.doi:10.1016/j.jip.2004.07.005.PMID15579317.
  179. ^Hull R (2002)."Chapter 12: Transmission 2: Mechanical, Seed, Pollen and Epidemiology".Matthews' Plant Virology(4th ed.). Academic Press. pp. 555–56.doi:10.1016/B978-012361160-4/50063-3.ISBN978-0123611604.Retrieved21 February2022.
  180. ^Zaheer K, Akhtar MH (2016). "Potato Production, Usage, and Nutrition – A Review".Critical Reviews in Food Science and Nutrition.56(5): 711–21.doi:10.1080/10408398.2012.724479.PMID24925679.S2CID33074838.
  181. ^Fuentes S, Jones RA, Matsuoka H, Ohshima K, Kreuze J, Gibbs AJ (July 2019)."Potato virus Y; the Andean connection".Virus Evolution.5(2): vez037.doi:10.1093/ve/vez037.PMC6755682.PMID31559020.
  182. ^Dinesh-Kumar SP, Tham WH, Baker BJ (December 2000)."Structure-function analysis of the tobacco mosaic virus resistance gene N".Proceedings of the National Academy of Sciences of the United States of America.97(26): 14789–94.Bibcode:2000PNAS...9714789D.doi:10.1073/pnas.97.26.14789.PMC18997.PMID11121079.
  183. ^Soosaar JL, Burch-Smith TM, Dinesh-Kumar SP (October 2005). "Mechanisms of plant resistance to viruses".Nature Reviews. Microbiology.3(10): 789–98.doi:10.1038/nrmicro1239.PMID16132037.S2CID27311732.
  184. ^Lomonossoff GP (2011). "Virus Particles and the Uses of Such Particles in Bio- and Nanotechnology".Recent Advances in Plant Virology.Caister Academic Press.ISBN978-1-904455-75-2.
  185. ^Wommack KE, Colwell RR (March 2000)."Virioplankton: viruses in aquatic ecosystems".Microbiology and Molecular Biology Reviews.64(1): 69–114.doi:10.1128/MMBR.64.1.69-114.2000.PMC98987.PMID10704475.
  186. ^Bergh O, Børsheim KY, Bratbak G, Heldal M (August 1989). "High abundance of viruses found in aquatic environments".Nature.340(6233): 467–68.Bibcode:1989Natur.340..467B.doi:10.1038/340467a0.PMID2755508.S2CID4271861.
  187. ^Bickle TA, Krüger DH (June 1993)."Biology of DNA restriction".Microbiological Reviews.57(2): 434–50.doi:10.1128/MMBR.57.2.434-450.1993.PMC372918.PMID8336674.
  188. ^Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, et al. (March 2007). "CRISPR provides acquired resistance against viruses in prokaryotes".Science.315(5819): 1709–12.Bibcode:2007Sci...315.1709B.doi:10.1126/science.1138140.hdl:20.500.11794/38902.PMID17379808.S2CID3888761.
  189. ^Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, et al. (August 2008)."Small CRISPR RNAs guide antiviral defense in prokaryotes".Science.321(5891): 960–64.Bibcode:2008Sci...321..960B.doi:10.1126/science.1159689.PMC5898235.PMID18703739.
  190. ^Mojica FJ, Rodriguez-Valera F (September 2016). "The discovery of CRISPR in archaea and bacteria".The FEBS Journal.283(17): 3162–69.doi:10.1111/febs.13766.hdl:10045/57676.PMID27234458.S2CID42827598.
  191. ^abWeiss RA (2017). "Exchange of Genetic Sequences Between Viruses and Hosts".Viruses, Genes, and Cancer.Current Topics in Microbiology and Immunology. Vol. 407. pp. 1–29.doi:10.1007/82_2017_21.ISBN978-3-319-61803-6.PMID28550453.
  192. ^Hu J, Ye H, Wang S, Wang J, Han D (2021)."Prophage Activation in the Intestine: Insights Into Functions and Possible Applications".Frontiers in Microbiology.12:785634.doi:10.3389/fmicb.2021.785634.PMC8710666.PMID34966370.
  193. ^Russ E, Iordanskiy S (January 2023)."Endogenous Retroviruses as Modulators of Innate Immunity".Pathogens.12(2): 162.doi:10.3390/pathogens12020162.PMC9963469.PMID36839434.
  194. ^Prangishvili D, Garrett RA (April 2004)."Exceptionally diverse morphotypes and genomes of crenarchaeal hyperthermophilic viruses"(PDF).Biochemical Society Transactions.32(Pt 2): 204–08.doi:10.1042/BST0320204.PMID15046572.S2CID20018642.
  195. ^Mojica FJ, Díez-Villaseñor C, García-Martínez J, Soria E (February 2005). "Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements".Journal of Molecular Evolution.60(2): 174–82.Bibcode:2005JMolE..60..174M.doi:10.1007/s00239-004-0046-3.PMID15791728.S2CID27481111.
  196. ^Makarova KS, Grishin NV, Shabalina SA, Wolf YI, Koonin EV (March 2006)."A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action".Biology Direct.1:7.doi:10.1186/1745-6150-1-7.PMC1462988.PMID16545108.
  197. ^van der Oost J, Westra ER, Jackson RN, Wiedenheft B (July 2014)."Unravelling the structural and mechanistic basis of CRISPR-Cas systems".Nature Reviews. Microbiology.12(7): 479–92.doi:10.1038/nrmicro3279.PMC4225775.PMID24909109.
  198. ^Dávila-Ramos S, Castelán-Sánchez HG, Martínez-Ávila L, Sánchez-Carbente MD, Peralta R, Hernández-Mendoza A, et al. (2019)."A Review on Viral Metagenomics in Extreme Environments".Frontiers in Microbiology.10:2403.doi:10.3389/fmicb.2019.02403.PMC6842933.PMID31749771.
  199. ^Zhang QY, Gui JF (December 2018). "Diversity, evolutionary contribution and ecological roles of aquatic viruses".Science China Life Sciences.61(12): 1486–1502.doi:10.1007/s11427-018-9414-7.PMID30443861.S2CID53564176.
  200. ^Weitz JS, Wilhelm SW (2013)."An ocean of viruses".The Scientist.27(7): 35–39.
  201. ^Suttle CA (September 2005). "Viruses in the sea".Nature.437(7057): 356–61.Bibcode:2005Natur.437..356S.doi:10.1038/nature04160.PMID16163346.S2CID4370363.
  202. ^Wilhelm SW, Suttle CA (1999)."Viruses and nutrient cycles in the sea: viruses play critical roles in the structure and function of aquatic food webs".BioScience.49(10): 781–88.doi:10.2307/1313569.JSTOR1313569.
  203. ^Shelford EJ, Suttle CA (2018)."Virus-mediated transfer of nitrogen from heterotrophic bacteria to phytoplankton".Biogeosciences.15(3): 809–15.Bibcode:2018BGeo...15..809S.doi:10.5194/bg-15-809-2018.
  204. ^abcdSuttle CA (October 2007). "Marine viruses – major players in the global ecosystem".Nature Reviews. Microbiology.5(10): 801–12.doi:10.1038/nrmicro1750.PMID17853907.S2CID4658457.
  205. ^Wigington CH, Sonderegger D, Brussaard CP, Buchan A, Finke JF, Fuhrman JA, et al. (January 2016)."Re-examination of the relationship between marine virus and microbial cell abundances"(PDF).Nature Microbiology.1(15024): 15024.doi:10.1038/nmicrobiol.2015.24.PMID27572161.S2CID52829633.
  206. ^Brussaard CP (2004). "Viral control of phytoplankton populations – a review".The Journal of Eukaryotic Microbiology.51(2): 125–38.doi:10.1111/j.1550-7408.2004.tb00537.x.PMID15134247.S2CID21017882.
  207. ^Robbins J (13 April 2018)."Trillions Upon Trillions of Viruses Fall From the Sky Each Day".The New York Times.Retrieved14 April2018.
  208. ^Reche I, D'Orta G, Mladenov N, Winget DM, Suttle CA (April 2018)."Deposition rates of viruses and bacteria above the atmospheric boundary layer".The ISME Journal.12(4): 1154–62.Bibcode:2018ISMEJ..12.1154R.doi:10.1038/s41396-017-0042-4.PMC5864199.PMID29379178.
  209. ^Hall AJ, Jepson PD, Goodman SJ, Harkonen T (2006). "Phocine distemper virus in the North and European Seas – data and models, nature and nurture".Biological Conservation.131(2): 221–29.Bibcode:2006BCons.131..221H.doi:10.1016/j.biocon.2006.04.008.
  210. ^DeLong JP, Van Etten JL, Al-Ameeli Z, Agarkova IV, Dunigan DD (January 2023)."The consumption of viruses returns energy to food chains".Proceedings of the National Academy of Sciences of the United States of America.120(1): e2215000120.Bibcode:2023PNAS..12015000D.doi:10.1073/pnas.2215000120.PMC9910503.PMID36574690.S2CID255219850.
  211. ^Irving M (28 December 2022)."First" virovore "discovered: An organism that eats viruses".New Atlas. Archived fromthe originalon 29 December 2022.Retrieved29 December2022.
  212. ^Broecker F, Moelling K (2019)."What viruses tell us about evolution and immunity: beyond Darwin?".Annals of the New York Academy of Sciences.1447(1): 53–68.Bibcode:2019NYASA1447...53B.doi:10.1111/nyas.14097.PMC6850104.PMID31032941.
  213. ^Lauer, A. (2021). Viruses, Underestimated Drivers of Ecology and Evolution of Life. In: Hurst, C.J. (eds) Microbes: The Foundation Stone of the Biosphere. Advances in Environmental Microbiology, vol 8. Springer, Cham.https://doi.org/10.1007/978-3-030-63512-1_28
  214. ^Forterre P, Philippe H (June 1999). "The last universal common ancestor (LUCA), simple or complex?".The Biological Bulletin.196(3): 373–75, discussion 375–77.doi:10.2307/1542973.JSTOR1542973.PMID11536914.
  215. ^Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J (2000)."Viruses: Structure, Function, and Uses".Molecular Cell Biology(4th ed.). New York: W. H. Freeman.
  216. ^Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, et al. (October 2005). "Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases".Journal of Infection and Chemotherapy.11(5): 211–19.doi:10.1007/s10156-005-0408-9.PMID16258815.S2CID8107934.
  217. ^Gleba YY, Giritch A (2011). "Plant Viral Vectors for Protein Expression".Recent Advances in Plant Virology.Caister Academic Press.ISBN978-1-904455-75-2.
  218. ^Jefferson A, Cadet VE, Hielscher A (September 2015). "The mechanisms of genetically modified vaccinia viruses for the treatment of cancer".Critical Reviews in Oncology/Hematology.95(3): 407–16.doi:10.1016/j.critrevonc.2015.04.001.PMID25900073.
  219. ^Karimkhani C, Gonzalez R, Dellavalle RP (August 2014). "A review of novel therapies for melanoma".American Journal of Clinical Dermatology.15(4): 323–37.doi:10.1007/s40257-014-0083-7.PMID24928310.S2CID38864550.
  220. ^"FDA approves Amgen's injected immunotherapy for melanoma".Reuters.27 October 2015.Retrieved24 January2020.
  221. ^Burke J, Nieva J, Borad MJ, Breitbach CJ (August 2015). "Oncolytic viruses: perspectives on clinical development".Current Opinion in Virology.13:55–60.doi:10.1016/j.coviro.2015.03.020.PMID25989094.
  222. ^Dogic Z (2016)."Filamentous Phages As a Model System in Soft Matter Physics".Frontiers in Microbiology.7:1013.doi:10.3389/fmicb.2016.01013.PMC4927585.PMID27446051.
  223. ^Fischlechner M, Donath E (2007). "Viruses as building blocks for materials and devices".Angewandte Chemie.46(18): 3184–93.doi:10.1002/anie.200603445.PMID17348058.
  224. ^Soto CM, Blum AS, Vora GJ, Lebedev N, Meador CE, Won AP, et al. (April 2006)."Fluorescent signal amplification of carbocyanine dyes using engineered viral nanoparticles".Journal of the American Chemical Society.128(15): 5184–89.Bibcode:2006JAChS.128.5184S.doi:10.1021/ja058574x.PMID16608355.
  225. ^Blum AS, Soto CM, Wilson CD, Brower TL, Pollack SK, Schull TL, et al. (July 2005). "An engineered virus as a scaffold for three-dimensional self-assembly on the nanoscale".Small.1(7): 702–06.doi:10.1002/smll.200500021.PMID17193509.
  226. ^Cello J, Paul AV, Wimmer E (August 2002)."Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template".Science.297(5583): 1016–18.Bibcode:2002Sci...297.1016C.doi:10.1126/science.1072266.PMID12114528.S2CID5810309.
  227. ^Coleman JR, Papamichail D, Skiena S, Futcher B, Wimmer E, Mueller S (June 2008)."Virus attenuation by genome-scale changes in codon pair bias".Science.320(5884): 1784–87.Bibcode:2008Sci...320.1784C.doi:10.1126/science.1155761.PMC2754401.PMID18583614.
  228. ^"NIH viral genome database".Ncbi.nlm.nih.gov.Retrieved28 June2021.
  229. ^Zilinskas RA (August 2017). "A brief history of biological weapons programmes and the use of animal pathogens as biological warfare agents".Revue Scientifique et Technique (International Office of Epizootics).36(2): 415–22.doi:10.20506/rst.36.2.2662.PMID30152475.
  230. ^abcArtenstein AW, Grabenstein JD (October 2008)."Smallpox vaccines for biodefense: need and feasibility".Expert Review of Vaccines.7(8): 1225–37.doi:10.1586/14760584.7.8.1225.PMC9709930.PMID18844596.S2CID33855724.
  • Media related toVirusesat Wikimedia Commons
  • Data related toVirusat Wikispecies
  • ViralZoneA Swiss Institute of Bioinformatics resource for all viral families, providing general molecular and epidemiological information